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5It ain’t what you don’t know that gets you into trouble. 
        It’s what you know for sure that just ain’t so.
The origin of this quote is in doubt. It is variously attributed to 
Mark Twain or Josh Billing but in reality, its origin is unknown.
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6ABSTR ACT
Dynamic capnography is a haemodynamic and respiratory monitoring tech-
nique enabling continuous cardiac output (Effective Pulmonary Blood Flow, 
COEPBF) and end expiratory lung volume (Effective Lung Volume, ELV) as-
sessment in mechanically ventilated subjects. The method utilizes variations 
in exhaled CO2, implemented via periods of deliberate changes in the respira-
tory pattern. The method has been validated against high precision reference 
methods in animal experiments. Data from these studies have pointed to a 
potential use also in children, a patient group suffering from the lack of reli-
able and easy accessible cardiac output/functional residual capacity (CO/FRC) 
monitoring methods. We have validated dynamic capnography in a series of 
paediatric clinical studies and experimental models. 
COEPBF was tested for agreement of absolute values and ability to detect 
change against suprasternal Doppler, COSSD, in anaesthetized children and 
against transpulmonary flow probe, COTS, in a porcine model mimicking the 
clinical study. COEPBF was also tested for the same qualities, against COTS and 
CO2 Fick (COFick) in a model of hypoxia induced pulmonary hypertension in 
piglets. The respiratory parameter ELV was examined for consistency against 
helium wash out in a paediatric rabbit model of CO2-induced pneumoperito-
neum. In addition to this, the same protocol was used to determine the PEEP 
level associated with most favorable conditions for preservation of lung homo-
geneity and CO2 clearance.
COEPBF showed good agreement and trending ability when compared to 
COTS and COFick in the experimental setting. In the clinical study, COEPBF 
performed in the expected way. The reference method COSSD exhibited opera-
tor dependent qualities and appeared less reliable than COEPBF. Absolute val-
ues and changes in FRC could be monitored adequately by ELV, provided the 
application an adequate PEEP. The adequate PEEP level was also associated 
with optimal preservation lung homogeneity and CO2 removal, thus suggest-
ing the use higher level of PEEP during laparoscopy.
Dynamic capnography appears to be a reliable and accurate method for 
continuous CO and FRC monitoring and is a promising concept for future 
studies.
Keywords: cardiac output; children; carbon dioxide; measurement;  
ultrasonic; hypertension, pulmonary; carbon dioxide; laprosocopy; PEEP; 
functional residual capacity
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9LIST OF ABBR EVIATIONS 
BTPS  Body Temperature and  
 Pressure Saturated
CO2  Carbondioxide 
CaCO2  Arterial CO2 content
CCCO2  Pulmonary end capillary  
 CO2 content
CVCO2  Mixed venous CO2 content
CO   Cardiac output
COEPBF  Cardiac output derived from  
 EPBF
COSSD  Cardiac Output assed with  
 suprasternal Doppler
COTS   Cardiac Output assed with  
 Transsonic Flow Probe
COFick  Cardiac Output derived   
 from direct CO2 Fick
CT  Computed tomography
CV  Coefficient of variation
Δtn  Current breath cycle time 
DC  Dynamic capnography
EELV  End expiratory lung volume
ELV   Effective lung volume
EPBF   Effective pulmonary blood  
 flow
FACO2 Alveolar CO2 fraction
FiO2   Inspired oxygen fraction
FRC   Functional residual capacity
He  Helium
iNO  Inhaled nitric oxide
LCI  Lung clearance index
LoA  Limits of agreement
LSC  Least significant change
MAP   Mean arterial pressure
MPE  Mean percentage error
n  Current breath
n-1  Previous breath
PAC  Pulmonary artery catheter
PECO2 Partial pressure of end tidal  
 CO2
PEEP   Positive end expiratory  
 pressure
PVR  Pulmonary vascular  
 resistance
Q  Flow
paO2   Systemic arterial oxygen   
 pressure
paCO2  Systemic arterial  
 carbondioxide pressure
SCO2   Solubility coefficient for CO2  
 in blood
SD   Standard deviation of the  
 mean
SF6  Sulfur hexafluroide 
TV  Tidal volume
VCO2   CO2 excretion
VTCO2 Volume of CO2 eliminated  
 by the current, nth, breath
VTI   Velocity time integral
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1  INTRODUCTION
The introduction of anaesthesia for surgical procedures is undoubtedly one 
of the most important additions to modern medicine when it was first initi-
ated in the mid 19th century. Anaesthesia has since then been the subject of a 
steady development with increasingly advanced and sophisticated treatment 
and monitoring options, all driven by the desire to provide safe and optimal 
care for the patient. 
The routine monitoring that is now considered mandatory during gener-
al anaesthesia offers continuous updates of physiological processes, which the 
early pioneers of anaesthesia could only dream about. At present, we can mon-
itor a plethora of such processes of more or less decisive character. However, 
despite that it has been more than a hundred years ago since the introduction 
of modern anaesthesia, some of the more vital physiological events are still 
difficult to follow in a reliable way. 
Cardiac output, the volume of blood pumped by the heart per minute, 
and functional residual capacity, the lung volume which is most important 
for gas exchange, are two examples of such processes. To be able to follow 
these parameters continuously and effortlessly must be regarded as one of the 
more sought after monitoring concepts in anaesthesia. Until recently there 
has been no readily available cardiac output or functional residual capacity 
monitoring method for children. The promising development of carbon diox-
ide-based cardiac output monitoring methods, ie Dynamic Capnography, in 
animals and adults has however opened up for this monitoring strategy also 
in children.
One of the purposes of all monitoring equipment is to provide the prac-
titioner with an information basis upon which decisions can be made, treat-
ment given or renounced. This places extremely high demands on the reliabili-
ty and precision of the method. This is especially true in paediatric anaestehsia, 
where the margin for error can be small. 
Added to this, methodologies should preferably be user-independent, re-
quire a minimum of education, be devoid of drift and recalibration and not 
requiring additional fluid administration.
The purpose of this thesis is therefore to provide a background of validation 
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and principle of cardiac output and functional residual capacity monitoring 
systems in children with special emphasis on Dynamic Capnography and to 
present a structured validation of Dynamic Capnography as a monitoring 
model in clinical and experimental paediatric studies.
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During anaesthesia and surgery it is important to continuously monitor the 
physiological status of the patient and this is particularly true for haemo-
dynamic and respiratory parameters.1 It is therefore desirable to be able to 
measure or at least estimate the patient’s cardiac output (CO) and functional 
residual capacity (FRC). In contrast to adult patients, where CO estimation us-
ing pulmonary artery catheter (PAC) thermodilution and complex tracer gas 
methods for FRC measurement, are accepted as “gold standards”, these tech-
niques are not routinely used in paediatric practice. This is mainly due to their 
cumbersome nature and increased risk of complications and these techniques 
are, thus, not suitable for continuous monitoring.2
For perioperative CO monitoring, the development of new methods have 
made the requirement for structured validations all the more crucial.3 Among 
these newer technologies are transpulmonary dilution techniques, Doppler 
measurements, arterial pressure curve-based CO monitoring and dynamic 
capnography (DC).4 Some, but far from all, of these technologies are properly 
validated for CO monitoring in children.5
The same applies for perioperative FRC monitoring where a limited num-
ber of  methods are available.6 The accuracy of these methods have been tested 
in adults but as for CO monitoring, results based on adult patient studies can-
not be directly directly extrapolated to paediatric practice, where the valida-
tion status for intraoperative FRC monitoring devices currently is insufficient.7
Since the majority of the CO and FRC monitoring options for paediatric 
care are intermittent, invasive, difficult to perform, needs recalibration and 
can not be used in newborn or small infants, the development a minimal-
ly-invasive, continuous, reasonably accurate and easy-to-use method would 
represent a seminal advancement of anaesthesia monitoring that would help 
guide therapy and most likely results in substantial benefits for many patient 
groups.8 One example of a method that potentially is associated with some 
these features is DC. DC is a methodology that determines changes in central 
haemodynamics and can also be used to estimate FRC but this methodology 
has not been possible to adapt to clinical use, until recently. DC uses modest 
predetermined variations of the respiratory pattern delivered by the ventilator 
2  BACKGROUND
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and combines this with high-precision, fast response, mainstream capnogra-
phy and advanced mathematics to generate continuous breath-by-breath cal-
culations of Effective Pulmonary Blood Flow (EPBF) and Effective Lung Vol-
ume (ELV). In a situation without major lung atelectasis EPBF has been found 
to closely equal CO.9
ELV represents the volume of the lung that takes part in actual gas ex-
change and is as such not a strictly defined anatomical volume and is therefore 
not exactly the same as FRC. However, ELV is very closely related to FRC and 
can by used as a proxy marker for FRC in the majority of scenarios.10,11  
This summary will give an overview on the background and rational for 
CO2 based CO and FRC measurement techniques in children and will focus 
more in detail on the development, validation and potential clinical useful-
ness of dynamic capnography in paediatric anaesthetic practice.  
Clinical relevance of CO monitoring in children
One of the main advantages of continuous CO monitoring is the possibility of 
early detection of deviations in circulatory status.12 This is of special impor-
tance when anaesthetizing small children where the margins for errors are 
small.13 Deviations in circulatory stability in children are today primarily de-
tected through change of heart rate and blood pressure, two methods where 
changes often occur late in the process and have relatively low specificity for 
an approaching in circulatory collapse. Changes in heart rate and blood pres-
sure may be caused by factors other than failing circulation, for example, by 
non-optimal dosing of anaesthetics.  
Looking ahead, there are studies indicating that the amount of intrave-
nous fluid given under anaesthesia can be guided with help from CO monitor-
ing by so-called stroke volume optimization.14 One can thus give the patient a 
tailor-made amount of fluid needed for the heart and other organs to function 
optimally, without risking giving too much or too little fluid. Currently, fluid 
administration in children is not individually adjusted but based on standard-
ized values calculated from the patient’s weight and metabolic need, which 
may increase the risk of improper amounts of fluids being given , with risk of 
fluid overload and hyponatremia.15 By continuously measuring CO, this risk 
could potentially be reduced. Furthermore, reliable information of CO is of 
great value when titrating inotropic and vasoactive drugs.
 CO monitoring thus provides the information necessary to choose be-
tween appropriate actions (or no actions) and monitor the response of the 
interventions. For these reasons, estimation of CO can be regarded as an 
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Figure 1. The relationship between PVR 
and lung volume. 
RV: Residual Volume, TLC: Total lung capac-
ity, PVR: Pulmonary vascular resistance 
Modified from West JB: Respiratory 
physiology—the essentials, ed 9, Baltimore, 
2012, Lippincott Williams & Wilkins.23
important part in the haemodynamics assessment of the vast majority of an-
aesthetized children.
FRC and the concept of end expiratory lung volume (EELV)
Mechanical ventilation often leads to loss of static lung volumes and forma-
tion of atelectasis with subsequent impaired ventilation.16 This can cause both 
intra- and postoperative complications.17 To counteract this, new concepts 
based on open lung ventilation strategies with recruitment maneuvers and 
positive end expiratory pressure titration and have emerged.18 Common to the 
majority of these strategies is the goal to ventilate around the patients FRC.19 
Strictly speaking, FRC refers to the lung volume at the end of expiration in a 
spontaneously breathing subject without adding positive end expiratory pres-
sure (PEEP). During mechanical ventilation the term end expiratory lung vol-
ume is often used and refers to the volume at the end of expiration when PEEP 
is applied. In practice however, both terms are used alternately with the same 
meaning.
There is currently a large body of evidence indicating that mechanical ven-
tilation is most effective and least damaging if performed around FRC, both 
in the normal and diseased lungs (e.g. acute lung injury).20 Ventilation around 
the patients FRC has also beneficial effects on the interaction between pulmo-
nary vascular resistance and pulmonary blood flow.21,22 Ventilation around 
FRC generally offers the lowest possible PVR and thus provides for optimal 
pulmonary blood flow and ventilation/perfusion conditions, as illustrated in 
figure 1 below. 
Given this, it would be of great value to find an easy-to-use methodolo-
gy that would help identify FRC, or something closely related to FRC. By do-
ing this, it would improve the chance of providing a lung-protective ventila-
tion strategy during anaesthesia and surgery, both in adults and children.16 
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Figure 1. The relationship between PVR 
and lung volume. 
RV: Residual Volume, TLC: Total lung capac-
ity, PVR: Pulmonary vascular resistance 
Modified from West JB: Respiratory 
physiology—the essentials, ed 9, Baltimore, 
2012, Lippincott Williams & Wilkins.23
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To attempt to quantify FRC during anaesthesia is currently not routine clini-
cal practice in adults or children since the available methods are too expensive 
and complex in the clinical context.24 The capnodynamic method for deter-
mination of effective lung volume however has the promise to estimate con-
tinuously EELV and pulmonary blood flow, the combination of which pro-
vide valuable assistance for the clinician in the haemodynamic and ventilation 
strategies during anaesthesia of children.
Aspects on how to validate new CO and FRC  
monitoring techniques in children
In order to properly validate new measurments techniques, the most common 
rationale is to compare their performance against known reference standards. 
The results are then subjected to a standardized evaluation system consisting 
of a number of statistical tests.25 There is currently an established structure 
on how to perform CO validation studies and it is generally recommended to 
follow this as far as possible, which we have had the ambition to do in the pa-
pers presented in this thesis. The structure defines suitable arrangements and 
statistical methods and is of great value for anyone involved in CO validation 
studies. 
 It’s important to emphasize that regardless of the choice and quality of the 
statistical methods used, the main problem with CO validation studies, ie the 
lack of a true gold standard, is still hard to get navigate. 
Statistical methods used in validation studies
The statistical methods often used and their limitations are explained in de-
tail below. 
Inherent precision
Defined as two times the coefficients of variation (CV) where CV=SD/mean 
(SD=standard deviation).26 It is important to report the precision of the refer-
ence method and the tested method since this partly defines the limits of ac-
ceptance of conformity between the methods. Inherent precision is also im-
portant when calculating the least significant change (LSC) as described in 
further detail below.
Correlation Coefficient 
Correlation coefficients, for example using Pearson correlation or Spearman, 
for assessing agreement between a tested method and a reference was fre-
quently used on early cardiac output validation studies and is still applied to 
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Figure 2. Example of a 
Bland Altman plot from 
study II.   
Black dotted lines  
represent bias and  
upper and lower limits  
of agreement. 
some extent in modern studies. Correlation coefficients shows the strength of 
the relationship between two measured variables and is an excellent indicator 
of this.27 However, one of the limitations with this method is that correlation 
only shows the strength of the linear relationship. It really says very little about 
the actual agreement of absolute values between the methods. This limitation 
has made the method less its popular in modern CO validation studies despite 
still being very useful to show a correlation. However, if correlation analysis is 
to be used however, presenting the coefficient with associated 95% confidence 
interval is probably advisable since this gives far more information than just 
presenting a singel correlation value. 
Agreement and Bias
Agreement between simultaneously recorded values of a tested method and 
a reference method are generally evaluated using Bland Altman analysis (28). 
One of the advantages of Bland Altman analysis is that it makes visual assess-
ment of the agreement easy. The difference between the paired measurements 
is plotted against the average of the measurements. Figure 2 below shows an 
example of a Bland-Altman plot from study II.
An interesting topic is whether the Bland Altman analysis should be correct-
ed for repeated measures.29 In our studies we have not corrected for repeated 
measurements, given that each measurments is performed in a new situation 
where the reference value varies in a minor to moderate manner and thus rep-
resents independent data. Consequently, this represents serial and not repeat-
ed measurements.30,31
The main difference if correction for repeated measures are applied however, 
is wider limits of agreement. 
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Bias and limits of agreement
Bias is defined as the mean difference between the tested method and the ref-
erence method in question. The spread of the included data points are present-
ed as limits of agreement (bias +/- (1.96xSD)).  One potential problem when 
interpreting the bias is that although the bias is small, the limits of agreement 
are often wide32,33,34 There is no general consensus on how wide the limits of 
agreement can be for the method to be accepted as clinically useful.25  Unfor-
tunately, the acceptable limits of agreement instead has to be defined on clini-
cal judgment. 
Bland-Altman analysis shows the overall bias and limits of agreement between 
two methods with the assumption that the differences between the compared 
methods are normally distributed.28 However, the bias and limits of agree-
ments may vary depending on the haemodynamic situation. If the haemody-
namic situation is at the extreme of the spectra, the bias and LoA may very 
well be different and if possible, bias and limits of agreement should ideally be 
presented for each haemodynamic state35 to overcome this problem. 
Mean percentage error (MPE)
Defined as 1.96 x SD of the difference between the tested techniques divided 
by the mean of the reference technique as suggested by Critchley.36 A mean 
percentage error less or equal to 30% is usually considered to indicate “inter-
changeability” between the tested  method and the reference method.36 The 
rational for using 30% as suggested by Critchley, lies in the inherent preci-
sion of the tested method and the reference technique.37 Critchley stated that 
if both methods tested have an inherent precision of 20%, the mean percent-
age error equals the square root of the product of the second power of the in-
herent precisions ie √(202 . 202) ie 28.4% which has been rounded off to 30%. 
However, since MPE is dependent on the inherent precision it is probably in-
appropriate to use 30% as the single cut off when approving a new method. In-
stead MPE should probably be analysed in the light of the inherent precisions 
of the tested method and the reference method.26 Other studies suggests that 
one can even accept a mean percentage error of up to 45% if the monitoring 
device has apparent advantages.38
Trending ability
The ability for a device to track changes are assessed by calculating the con-
cordance (the proportion of measurements that change in the same direction 
when two techniques are compared). An exclusion zone of 15 % is generally 
used as to compensate for statistical noise.35  The size of the exclusion zone is 
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related to the inherent precision of the reference methods and the LSC. The 
better the precision, the smaller the LSC and the smaller the exclusion zone 
should be considered.26 Strictly speaking if a reference method for example 
has precision of 10%, the LSC is 14% (10 . √2=14) and an exclusion zone of 15% 
should be considered.
Least significant change (LSC)
The LSC is the minimum change that can to be measured by a device in order 
to recognize it as a real change and is defined by the following equation: 
LSC = inherent precision . √2.26
If a reference method for instance has an inherent precision of 20 % one 
would need to design a protocol that changed the CO at least 20 . √2 = 28 % 
for the changes to be trusted as rea.26 The concept of LSC is particularly im-
portant when evaluating trending ability and exclusion zone for a study as de-
scribed above. 
Choosing reference method
When validating a new monitoring technique, it should be tested against a 
reference method using the statistical principles described above. In the nor-
mal case, CO studies examining new CO methods are conducted by compar-
ing a series of paired measurements between the tested method and a known 
reference, sometimes referred to as the “gold standard” method. These paired 
recordings are ideally done during both stable and unstable haemodynamic 
conditions25 to test the limit of the method and to examine the capability of 
the device to track changes. The ideal reference method should have good in-
herent precision, good estimation of absolute values, excellent rending ability 
and a short respons time.25
However, one of the main problems when validating new monitoring 
methods and CO monitors in particular is the lack of a true gold standard. In 
fact, there is no absolute clinical gold standard for CO monitoring and most 
methods have inherent precisions around 10% at the best.39 For many years, 
pulmonary artery thermodilution (PAC) have been considered a gold stan-
dard. However, even if performed under ideal circumstances, PAC generally 
holds a precision of only 20% to 10% at the best.40,41 
For laboratory use, ultrasonic flow probes placed around the pulmonary 
trunk (COTS) are generally regarded as gold standard. It has a reported in-
herent precision of less that 10%.42 For obvious reasons, COTS cannot be rou-
tinely used in humans. Instead methods such as PAC in adults or modified 
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CO2 Fick and trans pulmonary thermodilution in children are regarded as 
gold standards. However, these methods generally have lower precision40,41 
and need arterial and central venous access or even pulmonary artery cath-
eterization.  MRI is another method for CO estimation in children that is 
associated with good precision but has very limited role in intraoperative CO 
monitoring for evident reasons.43
For FRC measurements, inhaled helium wash-in/wash-out has a reported 
precision of around 12%44 during experimental conditions but the application 
of perioperative FRC monitoring devices are often subjected to off-label use 
and the reported precisions should probably be judged thereafter.45
It is also important to consider if the tested method measures continu-
ous or static values since validation of continuous methods may appear worse 
when compared to a reference methods that uses static values. This is particu-
larly true for measurements during haemodynamic and respiratory instability 
where the continuous method could in fact be more accurate.46 
Summary of background
Even if a tested methods agreement with a ”gold standard” is important, it is 
perhaps even more useful to evaluate if a new device can be used to initiate 
therapies and monitoring results of various interventions. To design a moni-
tor that as close as possible produce values in agreement with that obtained 
by “gold standard” such as PAC may therefore be redundant. Thus, an impor-
tant development in paediatric CO and FRC monitoring would be random-
ized outcome studies where the benefit of intraoperative CO/FRC monitoring 
to guide haemodynamic and ventilatory management is investigated against 
“best current practice”.47,48,49,50,51,52
FICKS PRINCIPLE AND DIFFERENTIATED FICK
The classic Fick method described by Adolf Fick 1870, is is still considered a 
gold standard for CO measurement.53 Fick’s equation is derived from the con-
servation of mass during pulmonary gas exchange. CO, or rather non-shunt-
ed pulmonary blood flow, is calculated from the oxygen consumption and the 
difference in arteriovenous oxygen content according to the formula:
Equation 1: VO2 is oxygen consumption, CaO2 pulmonary end capillary  
oxygen content and CvO2 is mixed venous oxygen content.
VO2 
(CaO2 – CvO2)
CO = 
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The method requires calorimetry for VO2 measurement, arterial and pul-
monary artery access and is therefore less suitable for routine clinical mon-
itoring.54 The equation can however be modified to include CO2 instead of 
oxygen. Replacing oxygen with CO2 as a tracer and applying the same princi-
ples gives the following equation:
Equation 2 VCO2 is carbondioxide elimination, CvCO2 mixed venous carbondioxide  
content and CaCO2 is pulmonary end capillary carbondioxide content.
Using direct CO2 Fick for CO estimation is applicable in clinical practice 
and the method has been validated in children.55 However, in analogy with 
oxygen Fick, the method is resource demanding and therefore rarely used.  
The concept of using CO2 as a tracer results in a significant simplification 
in CO2-based CO-monitoring since all components of the equation system 
can be determined through non invasive measurements.56 In 1988, Capek et al 
showed that CaCO2, can be calculated from the alveolar carbon dioxide frac-
tion using the CO2 dissociation curve.57  This concept allows for an easy way 
of estimating pulmonary end capillary CO2 content but it doesn’t take shunted 
CO2 into account. Strictly speaking, all CO monitoring models based on CO2 
Fick can therefore only calculate non shunted pulmonary blood flow.56
The other variable necessary for CO calculations, VCO2, can be deter-
mined using volumetric capnography.58 Still, even if CO2 and CaCO2 can be 
calculated from standard mainstream infrared CO2 sensor measurements, 
complex and potentially harmful pulmonary artery access is still required. 
The differentiated Fick method
The problem with the need for invasive CvCO2 measurement was partially 
overcome when Gedeon et al introduced the differentiated Fick method.59 
In differentiated Fick, simultaneous VCO2 and CaCO2 estimations are done 
at two separate occasions differed by a small change in alveolar ventilation. 
The first paired recording is done in a period of steady state after which a sud-
den perturbation in CO2 elimination is introduced and a second recording is 
done.59 
Provided that CvCO2 does not change during the brief change in CO2 
elimination, CvCO2 can be regarded as constant and thus shortened from 
equation 2. The subsequent equation for two time points with constant CvCO2 
separated by a small change in CO2 elimination can be expressed as; 
VCO2 
(CvCO2 – CaCO2)
C = 
20
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Equation 3: 1 and 2 indicates values at time point 1, steady state, and 2,  
after a change in CO2 elimination.
From standard algebra the following can be derived;
 
Equation 3 can therefore expressed as;
thus
Given the presumption that CvCO2 is constant between the changes in VCO2, 
Cv1CO2 is equal to Cv2CO2 therefore;
Provided that the partial pressure of end tidal CO2 (PECO2) is corrected for 
alveolar dead space, it can be assumed to equal CaCO2 which is in equilibrium 
with alveolar CO2  partial pressure thus; 
CaCO2 = SCO2 × PECO2  
Equation 4: SCO2 is the solubility coefficient of CO2 in blood and requires an estimate of 
the hemoglobin concentration and oxygen saturation SpO2 obtained from pulse oximetry.
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The change in end capillary CO2 content (ΔCaCO2) between the two points of 
different CO2 elimination is given by;
∆CaCO2 = SCO2 × (PECO21 – PECO22)
Equation 5
Substituting this in equation 1 gives us;
Equation 6
Equation 6 describes an elegant model for estimation of the pulmonary blood 
flow that participates in gas exchange, often called effective pulmonary blood 
flow (EPBF). By continuous monitoring of VCO2 and PECO2 , combined with 
a solubility constant dependent on hemoglobin level, barometric pressure and 
oxygen saturation from pulse oximetry and mathematical processing, the 
model can be used for CO monitoring in virtually any mechanically ventilat-
ed patient without the need for complex vascular access.56
The majority of the current CO2 based CO monitoring devices are based on 
the principle described in Equation 6. The difference between the methods 
lies mainly in how the change in CO2 elimination is created. The most com-
monly used approaches are cyclic variations in alveolar ventilation or partial 
rebreathing by variations in dead space.56 
Change in alveolar ventilation
In Gedeon’s original study, alterations in respiratory rate was used to induce 
perturbations in CO2 elimination. This was accompanied by a change in I:E 
ratio so that effectively only the end-expiratory pause was altered, provid-
ing the best possible conditions for pulmonary blood flow to remain constant 
throughout the change in ventilation.  Measurements could be repeated at 
maximum every 15th minute, to ensure that any possible fluctuations CvCO2 
caused by the respiratory pattern it self was minimized. The method showed 
good agreement against PAC  when tested in anaesthesised dogs.59
This method was further developed on 2002 with a modified mathemati-
cal formula and breathing pattern intended to cause less interference of the 
ventilation by shortening the perturbation periods from 15-30 seconds to a 3 
s end inspiratory pause of a single breath, followed by 1-3 normal breaths to re 
establish steady state . Gedeon validated the breathing pattern against PAC in 
adult cardiac surgery patients with good agreement.19
Because of the large capacity for the lungs to store CO2, any small change 
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in alveolar CO2 concentration changes the equilibrium required for equa-
tion 6 to be valid. Even if CvCO2 inflow to the alveoli is constant during the 
breathing cycle, CO2 can still be released to the alveoli from stores in the pul-
monary tissue.60 The CO2 gas exchange process between blood and alveoli 
must therefore be separated from the effects of changes in CO2, stored in the 
lung tissue. Gedeon approached this problem by the adding another variable, 
effective lung volume (ELV) to the equation.60 ELV can be viewed as a the 
combined volume of CO2 participating in gas exchange and CO2 stored in 
lung tissue. ELV should not be confused with the anatomical volume func-
tional residual capacity (FRC) although several studies have indicated that 
they are strongly related.10,11,20 
Variations in dead space by partial rebreathing
Capek and Roy developed an alternative approach to induce perturbations in 
CO2 elimination by cyclic variations in dead space. Dead space was varied by 
periods of partial rebreathing followed by normal ventilation. They found that 
even when the partial rebreathing period was limited to 30 s, CvCO2 remained 
largely constant allowing the method to give EPBF values every third minute 
thereby making it the first semicontinuous CO2 based CO monitor. Capek and 
Roy integrated the hemoglobin level into the mathematical formula to account 
for the effect of the hemoglobin level on the CO2 dissociation curve.57 An im-
portant finding from this was that large changes in hemoglobin concentration 
could cause errors in the EPBF calculations  making the system sensitive to 
shifts in hemoglobin. 
 A commercially available method, NICO (NICO Respironics, Murrys-
ville PA) is available where also shunt fraction is accounted for using Nunns 
iso shunt fraction plots.62 In adult practice, several clinical studies comparing 
partial CO2 rebreathing with PAC have shown a good level of agreement be-
tween the two methods.63 
Partial rebreathing by adding dead space have also been tested in chil-
dren.63  However the system is currently not validated for patients <15 kg or 
for tidal volumes <300 ml. It is technically challenging in children and re-
quires a period of haemodynamic stability for CO measurement. This makes 
this type of partial rebreathing system less ideal for paediatric and neonatal 
use where airway patency and circulatory status may vary considerable dur-
ing anaesthesia. Like other CO2-CO methods, the technique is also less reli-
able in situations with altered alveolar distribution of gas such as interstitial or 
obstructive lung disease.65 
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Capnodynamics
In 2006, Peyton et al. described a continuous breath-by-breath capnodynam-
ic approach to CO measurements based on differentiated Fick. Alveolar CO2 
changes were induced by serial changes in the tidal volumes in a preset rhyth-
mical fashion.66 
The principle, closely related to partial rebreathing methods, is based on a 
molar balance for pulmonary gas exchange. The mathematical and physiologi-
cal background for Peytons method is described below.
 At any given time, the volume of CO2 present in the lungs (VCO2) can be de-
scribed as; 
Equation 7. PACO2 is alveolar partial pressure of CO, PB is ambient barometric  
pressure, and VeffCO2 is the effective lung volume for carbon dioxide  
(cf. effective lung volume, ELV from Gedeon et al 2002).
The rate of change in VCO2,  dVCO2/dt, is depenent on influx of mixed venous 
CO2, outflow of end capillary CO2 and expired CO2. This can be expressed as;
Equation 8. VCO2; rate of elimination of carbon dioxide for any given breath,  
CvCO2 is the fractional content of carbon dioxide in mixed venous blood. SCO2,  
the  solubility coefficient of carbon dioxide in blood, for given conditions of temperature, 
hemoglobin, and oxygen saturation. PB barometric pressure.
Derivative of equation 7 gives
Equation 9
Substituting in equation 8 and transposing gives;
Equation 10
Equation 10 contains three unknown variables, VeffCO2, CvCO2 and Q.  In 
steady state, the right side reflects total CO2 production. The variables on the 
left hand side can be measured using volumetric capnography and analysis of 
end tidal partial pressure of CO2.  
Peyton used a continuous breath cycle consisting of six smaller and six 
PACO2 
PB
VCO2  =                  × VeffCO2
PACO2 
PB
= Q × CvCO2+VCO2-Q × SCO2 × 
dVCO2 
dt
dPACO2 
dt
=                   × 
dVCO2 
dt
VeffCO2 
PB
PACO2 
PB
×                    – VCO2  = Q × CvCO2 – Q × SCO2 ×
dPACO2 
dt
VeffCO2 
PB 
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larger tidal volumes, creating a change in alveolar CO2 continuously analyzed 
using the principle described in equation 10. The method was tested in me-
chanically ventilated sheep using transpulmonary ultrasonic flow probe as a 
comparator and showed good agreement of absolute values in periods of hae-
modynamic stability when compared to PAC.66 In 2012, Peyton described the 
use of step reductions in respiratory rate from 14 to 6 breaths/minute for a pe-
riod of 45 s accompanied by a change in I:E relationship from 1:2 to 1:6. This 
approach led to minimal interference with respiratory pattern and optimal 
conditions for stable mixed venous CO2 content since it effectively only affects 
the duration of the end expiratory pause. The method showed good agreement 
against PAC and esophageal Doppler when tested in adult cardiac surgery and 
in liver transplant patients.67
Peytons solution was the first application of differentiated Fick for contin-
uous breath-by-breath CO monitoring with a precision and accuracy well in 
level with other CO methods such as PAC. 
Current capnodynamic equations
In 2013 Albu et al reported the use of a variant of the differentiated Fick equa-
tion, to estimate FRC in anaesthetized rabbits.11 Changes in alveolar CO2were 
induced by variations in I:E relationship rather than manipulations of tidal 
volumes or respiratory rate. The continuous method used in Albus work is 
based on the molar balance for CO2 and is closely related to eq 10;
ELV · (FA CO2n− FA CO2n-1) =  
EPBF · ∆ t n · (Cv CO2 − Cc CO2n) − VT CO2n 
Equation 11
ELV, effective lung volume (liter) containing CO2 at the end of expiration; EPBF, effective 
pulmonary blood flow (liter min-1); n, current breath; n-1, previous breath; FACO2, alveolar 
CO2 fraction; CvCO2, venous carbon dioxide content (litergas literblood-1); CcCO2n, lung 
capillary CO2 content (calculated from FACO2); VTCO2n, volume (liter) of CO2 eliminated by 
the current, nth, breath; ∆ tn, current breath cycle time (min). 
By constantly changing the inspiratory and expiratory relationship in a 
preset rhythm of normal breaths with inspiratory/expiratory relationship of 
1:2, followed by a number of breaths with an extended expiratory pause (ap-
proximately 2 seconds, causing a functional lower respiratory rate), alveolar 
carbon dioxide concentration changes approximately 0.5-1 kPa.61 This change 
in alveolar carbon dioxide concentration and elimination is related to the alve-
olar blood flow as described in Equation 11. Each breathing analysis sequence 
consists of a number of breaths, commonly 9 or 10.10,11,68,71 Every breath 
creates a new separate equation. Thus, a series of breaths generates an equal 
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number of equations with 3 unknown variables (EPBF, ELV, CvCO2). By opti-
mizing the fit between the lung model and measured data, the equation system 
described above can be solved. The equation also makes it possible to quantify 
ELV. The calculations made are compared to an ideal one-lung compartment 
model. If the differences between measured data and data calculated from the 
ideal model are outside the limits of acceptance, no values of ELV or EPBF are 
obtained. This gives the method a built in error-detection system to avoid the 
risk of displaying false values. 
Recent publications by Albu and Hällsjö Sander et al61,68,69 have described 
the use of this continuous dynamic capnography for assessment of CO and 
FRC in animals and by our research group also in infants.70 Agreement with 
other CO established comparators has been encouraging in these studies and 
associated with good trending capabilities. The structure of the pattern has 
been refined and the method tested against “gold standards” under normal 
and variable physiological situations as described below. 
Validation of capnodynamics for CO and FRC estimations
In Albus study from 2013, the capnodynamic approach described in equation 
11 was used for ELV measurements in mechanically ventilated rabbits exposed 
to various PEEP levels.  The method was validated against multiple breath he-
lium wash out and a breathing pattern of five normal breaths followed by five 
breaths with approximately 2 seconds inspiratory pause.11 ELV showed good 
agreement and ability to track changes in FRC in response to PEEP chang-
es when compared with helium method.  In another animal study by albu in 
2015, ELV was compared against helium wash out and computer tomography 
(CT) at different PEEP levels before and after surfactant depletion in rabbits. 
Again, ELV showed promising capability of continuous lung volume monitor-
ing before and after lung lavage.10
A study by Hällsjö et al tested a similar experimental respiratory pattern 
using six normal breaths and three breaths with 2 expiratory pause. The meth-
od was compared with SF6 tracer gas wash out in pigs exposed to a series of 
haemodynamic challenges.71 ELV showed a good agreement (mean percent-
age error 36%) and trending ability (concordance rate 93%) when compared 
with sulfur hexafluroide (SF6) wash out. A key finding in this study was that 
ELV measured with expiratory hold appeared robust to changes in CO and 
pulmonary blood flow.  They concluded that an expiratory hold potentially in-
fluences pulmonary blood flow to a lesser extent than inspiratory hold there-
by optimizing the conditions for constant CvCO2 during each measurement 
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cycle as stated by Gedeon.60
In a porcine model with intact lungs, by Hällsjö et al, dynamic capnogra-
phy was used according to eq 11, to compared DC with  PAC and pulmonary 
artery flow probe in a study involving a series of haemodynamical challenges 
(68).  A breathing pattern of five normal breaths and five breaths with inspira-
tory pause was used. Even if overall bias was low and trending abilities good, 
a mean percentage error was 48% indicating less that optimal agreement be-
tween the methods.
In a similar study 2015 using the same breathing pattern, dynamic cap-
no-graphy was tested in a porcine model of lung lavage-induced surfactant 
depletion. Lung lavage leads to impaired gas exchange and has been a known 
to be an aggravating factor for other techniques based on differentiated fick 
methods.69 When shunt fractions increased after lung lavage both the agree-
ment and precision was impaired (mean percentage error increased from 36 
to 70%), as with most described CO2 based CO methods. However, trending 
ability was well-preserved even after the lavage.
In 2017, Sigmundsson et al examined the same breathing pattern as Häll-
sjö 201672 to test the capnodynamic method by using a porcine ischemia- 
reperfusion and hypercapnia model to create rapid changes in CvCO2 levels. 
COEPBF accuracy was found to be impaired during periods of reperfusion but 
agreement was restored within 5 minutes after reperfusion.  Prolonged hyper-
capnia did not affect COEPBF in this study.
Summary of dynamic capnography
The development of minimally invasive CO2 based CO monitoring methods 
in the adult world has resulted in a number of breath-by-breath methods that 
are accurate and easy-to-use. The methods are currently tested in paediatric 
animal models and in the clinical context with promising results. 
Current research has focused mainly on standardized validation against 
gold standards, mainly PAC and transpulmonary flow probe.  The results are 
promising and dynamic capnography shows inherent precision and accuracy 
well in level with PAC for most situations. However, the real challenge for dy-
namic capnography, testing its clinical usefulness, remains to be carried out. 
Randomized trials of CO guided haemodynamic therapy are therefore most 
likely the next natural step in the process of determine whether dynamic cap-
nography is an effective adjunct to the existing clinical monitoring, especially 
with respect to morbidity and mortality in critically ill children. 
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ASPECTS ON RESEARCH COLLABORATION  
WITH THE MEDICAL INDUSTRY
Paper I, II and III have all partially been funded by unrestricted grants from 
Maquet Critical Care AB, Solna Sweden, as stated in each manuscript. Re-
search sponsored by the medical industry is occasionally met with doubt and 
even runs the risk of being seen as tainted. Rightly, this raises a few consider-
ations worth highlighting. 
Currently, non-government resources sponsor more than half of the in-
vestigation at Karolinska Institutet and the medical industry contributes sig-
nificantly to this funding.73 Firstly, it is important to emphasize that Karolin-
ska Institutet encourages research collaboration with the medical industry, 
illustrated by a statement in the text “Corporate partnering at Karolinska In-
stitute” 74:
“Karolinska Institutet welcomes and strongly encourages partnerships with 
industry in order to realize the potential of research findings and knowledge 
generated at the university. Partnerships are deemed important for building 
further excellence in research, education and innovation”
Furthermore, neither academia nor the medical industry is immune from 
ethical responsibility or liability and government funded projects offers no 
natural protection  from factors that risk threatening the objectivity of re-
search (please c.f. Macchiarini scandal).
With state-funded research constantly at risk of declining, academic in-
stitutions in general are increasingly relying on external funding. Following 
this intensified engagement between academia and industry, it is important to 
adapt an approach and awarness to protect the credibility of the partnership. 
As with any research project, regardless source of funding, accuracy and vig-
ilance can minimize bias and provided that studies are planned, performed 
and reported to minimize this, by researches whose income is not depending 
on the method being evaluated, there is no decisive reason why the interests of 
the academia and industry can not be aligned in this context.
To further safeguard the academic intergrity of this project, it was decided 
from the onset that the supervisors of the thesis was only academia-based.
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and reported to minimize this, by researches whose income is not depending 
on the method being evaluated, there is no decisive reason why the interests of 
the academia and industry can not be aligned in this context.
To further safeguard the academic intergrity of this project, it was decided 
from the onset that the supervisors of the thesis was only academia-based.
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3  AIMS
1. To assess the feasibility of COEPBF for agreement of absolut values and  
ability to track changes in CO when compared to the current standard,  
supra-sternal Doppler (COSSD), in the human clinical setting (Study I).
2. To validate COEPBF in a porcine model of selective pulmonary vasocon-
striction, a situation challenging the EPBF method with regards to isolated 
right ventricular workload and intrapulmonary CO2 content (Study II).
3. To characterize the PEEP-level needed to preserve FRC, ventilation  
homogeneity and allow for adequate CO2 clearance in a paediatric model 
of laparoscopic surgery (Study III).
4. To compare capnodynamic ELV with the gold standard, helium  
wash-in/wash-out FRC method, at the PEEP level resulting in adequate 
lunghomogeneity, in the same model of paediatric laparoscopic surgery 
(Study III).
29
3  AIMS
1. To assess the feasibility of COEPBF for agreement of absolut values and  
ability to track changes in CO when compared to the current standard,  
supra-sternal Doppler (COSSD), in the human clinical setting (Study I).
2. To validate COEPBF in a porcine model of selective pulmonary vasocon-
striction, a situation challenging the EPBF method with regards to isolated 
right ventricular workload and intrapulmonary CO2 content (Study II).
3. To characterize the PEEP-level needed to preserve FRC, ventilation  
homogeneity and allow for adequate CO2 clearance in a paediatric model 
of laparoscopic surgery (Study III).
4. To compare capnodynamic ELV with the gold standard, helium  
wash-in/wash-out FRC method, at the PEEP level resulting in adequate 
lunghomogeneity, in the same model of paediatric laparoscopic surgery 
(Study III).
29
30
The methods used are described in more detail in each paper. Below is a gen-
eral presentation of the methods used.
Settings and ethical permits
Study I is divided into two parts, one clinical and one experimental. The clini-
cal part of study I was performed at the Karolinska University Hospital, Stock-
holm, Sweden and the experimental part of study I and II was performed in 
the Hedenstierna Laboratory, Uppsala University, Uppsala, Sweden. The clini-
cal part of study I was approved by Internal Ethical Review Board approval 
and Parental Informed Consent (verbal and written) was collected before ini-
tation of the study.
 For the experimental part of study I and study II, approval from Uppsala 
Animal Ethics Committee Uppsala, Sweden was obtained. 
Study III was performed at The Unit for Anaesthesiological Investigations, 
Dept. of Anesthesiology, Pharmacology and Intensive Care, University of Ge-
neva, Geneva, Switzerland and the experimental protocol was approved by the 
institutional ethics committee for experimental research of the University of 
Geneva and animal welfare committee of the Canton of Geneva, Switzerland. 
Further details of the etichal permits can be found in each paper. 
Patients and animals
Patients (study I)
15 children (median age 8.5 months range 6-23 months; median weight 8.3 kg 
(range 7.8-10.5 kg), scheduled for surgical cleft lip-palate repair, were includ-
ed. Exclusion criteria were concomitant systemic illness, known heart disease, 
ongoing medication, American Society of Anesthesiology risk class 3-4. 
Anaesthetic procedure study I
Induction of anaesthesia was either inhalational (Sevoflurane) or intravenous 
(Propofol). Anaesthesia was maintained using a standardized intravenous reg-
imen with propofolinfusion mg kg-1 and bolus dose fentanyl 1 mcg kg-1. Ro-
curonium 0.5 mg kg-1 was used for muscle relaxation. The patients were pre-
oxygenated (FiO2: 1.0) and the airway was secured using a cuffed endotracheal 
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tube of age adequate dimension (Microcuff® Pediatric ETT, Kimberly Clark, 
Health Care, Atlanta, GA, USA) with the cuff inflated to allow an adequate 
airtight seal.  Following endotracheal intubation the patient was connected to 
a ventilator equipped with additional software creating the breathing pattern 
required for COEPBF determination (Servo I, Maquet Critical Care, Solna. Swe-
den). This was subsequently followed by a standardized lung recruitment ma-
neuver, using FiO2 0.3 with positive end expiratory pressure (PEEP) 8 cm H2O 
and tidal volumes (TV) 6-8 ml kg-1 for 2 min.
Research animals and preparation
Pigs (I, II)
In paper I 9 pigs with a mean weight of 23.6 kg  (range 23.4 – 24.8 kg, age 6-8 
weeks) were used. In paper II, 10 pigs with median weight 23.9 kg  (range 23.5 
– 24.6 kg, age 6 to 8 weeks) were used. Both study I and II used animals col-
lected from the same breeding colony (Mångsbo Farm, Uppsala, Sweden).
Rabbits (III)
Eight adult rabbits (chinchilla breed), median weight of 3.7 kg (range 3.6-3.9 
kg), were collected from the same breeding colony (University Farm Arare, 
Canton of Geneva, Switzerland). 
Anaesthetic and surgical preparation study I and II
Shortly after arrival to the laboratory, the pigs were sedated with 0.04 mg kg-1 
atropine (NM Pharma AB, Sweden), 6 mg kg-1 tiletamine-zolazepam (Zoletil, 
Vibrac Laboratories, France), and 2.2 mg kg-1 xylazine chloride (Rompun, 
Bayer AG, Germany) administered intramuscularly. Infusion of 5 μg kg-1 fen-
tanyl (Fentanyl B. Braun, Germany), ketamine 30 mg kg-1 h-1, midazolam 0.1 
mg kg-1 h-1 and fentanyl 4 μg kg-1 h-1 was used for maintenance of anaesthesia 
and rocuronium 2 mg kg-1 h-1for muscle relaxation. Ringer’s acetate 10 ml kg-1 
h-1 was administered throughout the experiment.
After tracheostomy, normoventilation was achieved (pressure control 
mode with  Servo I, Maquet, Solna, Sweden): tidal volume 10 ml kg-1, FiO2 
0.4 and PEEP 5 cm H2O. A balloon-tipped 7.5 Fr PAC was inserted via the 
right jugular vein into the pulmonary artery and the jugular vein and carotid 
artery were cannulated for pressure recordings and blood sampling. A uri-
nary Foley catheter was inserted into the urinary bladder. Through a left 
sided thoracotomy, an ultrasonic flow probe was placed around the pulmo-
nary trunk for continuous measurement of COTS as shown in Figure 4. The 
thorax was then closed and the animals placed in a supine position. Lung 
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recruitment was done using a peak pressure of 20 cmH2O, PEEP 10 cmH2O 
with I:E 1:1, respiratory rate 10 for 2 minutes. The body temperature was main-
tained at 38 – 39C. 
After preparation, the piglets were allowed a 15-minute stabilization pe-
riod before the initation of the study protocols.
Following the end of studies, the pigle were euthanized according to estab-
lished standard at the laboratory.
Pressure readings and signals from the ultrasonic flow probe were sam-
pled into a data acquisition system (version 3.2.7, Acknowledge, BioPac Sys-
tems, Santa Barbara, CA, USA).
Anaesthesia and surgical preparation III
The rabbits were anaesthetized by an intramuscular injection of xylazine 
(3 mg kg-1) and ketamine (15 mg kg-1) followed by an iv injection of propofol 
(2 mg kg-1). Following tracheotomy, an endotracheal tube (4 mm i.d, Portex®, 
Smiths Medical, Kent, UK) was inserted into the distal trachea. The jugular 
vein and carotid artery were cannulated for pressure recordings and blood 
sampling. Mechanical ventilation was started (volume control mode) with tid-
al volume 7 ml kg-1 and respiratory rate adjusted to achieve normocapnea (5.5-
6.0 kPa) and using an inspired oxygen fraction (FiO2) of 0.4. The ventilator 
was equipped with the same additional software as used in all studies, creating 
the breathing pattern required for ELV determination (Servo I, Maquet Criti-
cal Care, Solna, Sweden). 
Anaesthetic maintenance was achieved by a continuous intravenous infu-
sion of propofol (10 mg kg-1 h-1) and fentanyl (50 μg kg-1 h-1) via an ear vein. 
All rabbits received continuous Ringer-acetate infusion for volume compensa-
tion (4 ml-1  kg-1 h-1). Atracurium was given for  muscle  paralysis (0.5-1.0 mg 
kg-1 h-1) after confirming an adequate level of anaesthesia and analgesia. Car-
bon dioxide was insufflated to the abdominal cavity through a small airtight 
incision, using a commercially available intra-abdominal CO2 insufflation de-
vice for surgical use (Electronic Endoflator, Karl Storz, Tuttlingen, Germany) 
to regulate IAP. Airway pressure, heart rate and rectal temperature were dis-
played and stored on a computer at a sampling rate of 1 kHz via an analog/ 
digital interface converter (ADInstruments, Powerlab model 8/35 and Lab-
Chart 7, Dunedin, New Zealand).  Following completion of the protocol, the 
animals were euthanized according to established standard at the laboratory.
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Reference methods used for CO monitoring
Supra sternal pulsed Doppler (COSSD) (Study I)
COSSD was measured by a single highly experienced sonographer and the 
measurements were performed using a Philips ultrasound system (Philips CX 
50, S8-3 probe Philips Healthcare 3000 Minuteman road Andover, MA 01810 
USA). 
After establishing a satisfactory quality 2D parasternal long axis view, 
the aortic diameter was measured at the aortic valve annulus. Two consecu-
tive aortic diameter measurements were made and the mean of the two values 
was used for CO calculations. To minimize error in angulation, the ascend-
ing aorta was insonated from the jugular notch using 2D and color Doppler.75 
The flow velocity was measured with pulsed Doppler and the sample volume 
placed just above the aortic valve.  Care was taken to find the maximum ve-
locity and after a stable Doppler signal was obtained the velocity time integral 
(VTI) was recorded over 6-12 consecutive beats (mean 8) with no specific tim-
ing to any of the sections of the capnodynamic breathing cycle. The mean VTI 
for one beat was then multiplied by the aortic valve area and the heart rate to 
obtain CO. Figure 3 below shows an example of a series of Doppler recordings 
made with COSSD. 
Figure 3. Doppler trace of the COSSD method. Each blue spike represents one VTI, the area 
corresponding to one stroke volume.
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Pulmonary artery ultrasonic flow probe (COTS) (Study I and II)
Pulmonary artery ultrasonic flow probe (AU-series COnfidence Flowprobe® 
with ultrafit circle liner, Transonic System, Inc., Ithaca, NY, USA), COTS,  was 
used in studies I and II. The signals from the ultrasonic flow probe were sam-
pled into a sampling device (T 401; Transonic System, Inc., Ithaca, NY, USA) 
according to the instructions from the manufacturer. A filter of 0.1 Hz was 
used to display the average value over 10 seconds.
COTS estimates flow by passing ultrasonic signals back and forth through 
flowing blood, alternately intersecting the blood flow in upstream and down-
stream directions. A precise measure of the time it takes for for the ultrasound 
wave to travel from one transducer to the other can then be used to measure 
flow (rather than to measure velocity, which is the base for Doppler estima-
tions of flow).42 The COTS measurments is thus not depending on vessel cross 
sectional area. Figure 4 below show the COTS probe in situ in a research ani-
mal.
Figure 4.   
The transpulmonary 
flow probe in situ in a 
research animal.
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CO2 based Cardiac Output estimation (COFick) (II)
COFick was determined by simultaneous arterial and mixed venous blood gas 
measurements and calculations of CO2 content (ml dL-1) in whole blood76 
and CO2 elimination  (VCO2, ml min-1) recorded by volumetric capnogra-
phy via the ventilator (77). COFick was determined using the equation below. 
 
VCO2, CO2 elimination (ml min-1); cvCO2, mixed venous CO2 content 
(ml L-1); caCO2, arterial CO2 content (ml L-1).
VCO2 measurement using volumetric capnography (I,II,III)
VCO2 was calculated continuously with volumetric capnography us-
ing data from standard measurements of end-tidal CO2 concentration with a 
mainstream infrared CO2 sensor (Capnostat-3, Respironics Inc, Wallingford, 
CT, USA) inserted between the endotracheal tube connector and the standard 
Y-piece. Ventilation airflow was recorded by the standard Y-piece flow sensor 
of the Servo I ventilator. The tidal CO2 elimination rate (VCO2 ml min-1) was 
then calculated using data from the ventilator and main stream capnograph 
with this setup.   
End expiratory lung volume measurments  
with heliun wash out 
EELV in study III was determined by the helium multiple-breath wash-out 
technique (Exhalyzer D; ECO Medics AG, Dürnten, Switzerland). An ultra-
sonic flow meter (Spiroson Scientific; ECO Medics AG, Dürnten, Switzerland) 
was inserted between the endotracheal tube connector and the ventilator cir-
cuit to measure changes in molar mass of the respiratory gas. Helium was dis-
pensed into the inspiratory limb of the ventilatory circuit to reach an end-in-
spiratory concentration of 4-5%  after which the recording was started. The 
helium flow was then interrupted, and the washout dilution of the tracer gas 
was recorded. EELV was calculated from the changes in the He concentra-
tion during the wash out phase by a special software, (Spiroware, V1.4.3, ECO 
Medics AG, Dürnten, Switzerland).10,11
Lung clearance index  (LCI) (III)
LCI was calculated as the number of lung volume turnovers required to de-
creasing the helium concentration to 1/40th of the starting value.78 LCI has 
been used in paediatric practice as an indicator of ventilation heterogeneity 
VCO2 
(CvCO2 – CaCO2)
C = 
35
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and is a sensitive marker of small airway collapse.78 The normal value in 
healthy children is approximately 6, with a low LCI value indicates a situation 
of more homogenous ventilation.79
COEPBF and ELV estimations
In all three studies, COEPBF and ELV were calculated using the capnodynamic 
method. The development and theory behind the capnodynamic method, us-
ing the Differential Fick’s principle, is described in further detail in the back-
ground section of this thesis.  In short, the method is based a molar balance 
for CO2 as described in the equation below:
ELV · (FACO2n− FACO2n-1) = EPBF · ∆ tn · (CvCO2 − CcCO2n) − VTCO2n 
ELV, effective lung volume (liter) containing CO2 at the end of expira-
tion; EPBF, effective pulmonary blood flow (liter min-1); n, current breath; n-1, 
previous breath; FACO2, alveolar CO2 fraction; CvCO2, venous carbon dioxide 
content (litergas literblood-1); CcCO2n, lung capillary CO2 content (calculated 
from FACO2); VTCO2n, volume (liter) of CO2 eliminated by the current, nth, 
breath; Δ tn, current breath cycle time (min).  
The ventilator continuously delivers a breathing pattern consisting of 
series of six breaths with an inspiratory/expiratory relationship of 1:2 followed 
by three breaths with approximately 2 seconds expiratory pause as shown in 
Figure 5 below. The pause causes a 0.5 to 1 kPa increase in alveolar CO2 con-
centration as well as an increase in CO2 elimination, proportional to alveolar 
blood flow. The change in alveolar CO2 concentration and elimination cor-
relates to COEPBF and ELV as described in Equation 1. Each breathing analy-
sis sequence consists of 9 breaths. Every breath creates one separate equation. 
Figure 5. A 
snap shot of the 
ventilatory and 
capnographic 
trace from the 
experimental 
breathing pat-
tern used in 
all studies ie a 
series of breaths 
with normal I:E 
relationship, 
followed by a 
series breaths 
with expiratory 
pause.
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Thus, 9 breaths generate 9 equations with 3 unknown variables (ELV, EPBF 
and CvCO2). By optimizing the fit between an ideal one compartment lung 
model and measured data, the equation system described above can be solved.
Figure 6 below shows a snap shot of the computer system where EPBF and 
ELV values are displayed, along with the volumetric capnogram and other re-
spratory parameters. 
 
The method does not take shunted blood into account, but in the absence 
of cardiac or pulmonary shunting, COEPBF will be closely related to pulmo-
nary blood flow and thus systemic CO.60
Effective Lung Volume (ELV) (III)
The capnodynamic equation also makes it possible to quantify ELV (as 
shown in Equation 11), which corresponds to the lung volume participating in 
gas exchange including the airway volume up to the site of the CO2 sensor and 
Figure 6. Snap shot of the experimental computer system used for data recording from 
study I. Note the EPBF and ELV panels to the far right and the PEEP panel to the left. EPBF 
decreases and ELV increases during elevation from PEEP 3 to 10 cmH2O. 
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the carbon dioxide dissolved in lung tissue and lung capillary blood.11 Provid-
ed that adequate PEEP is applied, ELV is closely related to FRC during most 
circumstances.10,11,71
Mainstream capnography (I, II and III)
COEPBF as well as ELV was calculated continuously using data from standard 
measurements of end-tidal CO2 concentration with a mainstream infrared 
CO2 sensor (Capnostat-3, Respironics Inc, Wallingford, CT, USA) inserted be-
tween the endotracheal tube connector and the ultrasonic flow meter.  Venti-
lation airflow was recorded by the standard Y-piece flow sensor of the Servo I 
ventilator. The tidal CO2 elimination rate (VCO2 ml min-1) was calculated us-
ing data from the ventilator and mainstream capnograph.55
All lung volumes are corrected to Body Temperature and Pressure Satu-
rated (BTPS).
The mathematical analysis required for the continuous COEPBF and ELV 
calculation in I, II and III was done in Matlab (MatlabTM, The Mathworks 
Inc, Natick, MA, USA).
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Protocols
Inherent precision measurments I, II, III
Inherent precision measurments for DC were performed in all studies during 
stable baseline conditions, before the starting the study protocols. In study I 
clinical part, inherent precision was calculated from three initial paired COEPBF 
and COSSD baseline recordings. In the laboratory part of study I and in study 
II, 10 consecutively paired recordings 1 minute apart of COEPBF and COTS 
were used. 
In study III, inherent precision of ELV was determined for each PEEP level 
using continuous measurements recorded over 3 minutes (about one hundred 
ELV values). 
Study I
In study 1 COEPBF was validated against COSSD during clinical conditions. 
Due to the variable performance of COSSD, a porcine study was subsequently 
performed that mimicked the clinical protocol but instead we used COTS as 
comparator.  Figure 7 below shows the scheme of the protocol for study I clini-
cal part.
After a five-minute stabilization period following endotracheal intubation the 
study sequence was performed.
a. Three baseline CO measurements were performed one minute apart, 
COSSD and COEPBF recorded simultaneously.
b. PEEP was increased from 3 to 10 cmH2O (expected to produce a reduction 
of CO). CO measurements were performed at 1, 3 and 5 minutes following 
the PEEP increase.
c. PEEP was then turned down to 3 cmH2O and new baseline recordings of 
CO were performed after 1 and 3 minutes.
d. Finally the patients were administered an intravenous bolus of Atropine 
20μg kg-1 (expected to increase CO). COEPBF and COSSD were then record-
ed 1, 3 and 5 minutes after atropine administration, following which the 
protocol was stopped. 
Figure 7. Scheme of the 
study protocol for the 
clinical part of Study I.
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Protocol experimental part
The pigs were subjected to the same study protocol as used in the clinical part 
of the study with the following exception:
• Based on previous experience, piglets need 40 μg kg-1 of intravenous atro-
pine to display a reliable haemodynamic response and was, thus, used in-
stead of the 20 μg kg-1 used in the clinical part of the study.
Study II
In study II we compared COEPBF with COFick and COTS for its ability to 
estimate absolute values and track changes in CO in a porcine model of 
hypoxia-induced selective pulmonary hypertension and subsequent inhaled 
nitric oxide treatment. 
After baseline recordings, FiO2 was decreased in two steps from 1.0 to 0,5 
and 0.21. At FiO2 below 0.21, inspired oxygen concentration was then slowly 
reduced in small increments, approximately every tenth minute using a gas 
mixture of air and nitrogen to achieve a 100% increase in PVR from the base-
line recorded at FiO2 1.0. 20 PPM inhaled nitric oxide was then added by an 
inhaled nitric oxide supplying device (SoKinox™, Air Liquide, Paris, France). 
Three minutes after the inhalational NO concentration reached 20 PPM, 
paired recordings of all COEPBF, COFick and COTS were done. FiO2 was then 
gradually increased in small increments to 0.21, and then stepwise to 0.5 and 
1.0. At each step, time was allowed for haemodynamic stabilization before si-
multaneous COEPBF, COTS and COFick recordings were done. Figure 8 shows 
the study protocol for study II.
Figure 8. Scheme of the study protocol for Study II. COEPBF, COTS and COFick was recorded 
simultaneously at all seven time points illustrated.
Study III
In study III we examined the optimal PEEP level needed to preserve FRC, LCI, 
and VCO2 during a model paediatric of laparoscopy with CO2 pneumoperito-
neum. We also aimed at validating ELV for its capability of bedside FRC esti-
mations in the same setting.
Before the start of the protocol, the lungs were recruited using PEEP 3 
cmH2O, 14 ml kg-1 tidal volume while applying a 10 seconds inspiratory hold. 
This procedure was repeated once and used as standardized recruitment be-
tween PEEP level changes throughout the protocol.10 After this, the rabbits 
were ventilated in the volume control mode, tidal volumes of 7 ml kg-1, PEEP 
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3 cmH2O and FiO2 0.4. Respiratory rate was adjusted to reach normocapnea 
(5.5-6 kPa). The capnodynamic breathing pattern used for ELV estimations 
was then started.
Paired ELV and EELV measurements were made at IAP 0 mmHg and 
PEEP of 3 cmH2O. The IAP was then randomly varied between 0, 6 and 12 
mmHg. The paired recordings were collected 3 minutes after the desired IAP 
level had been achieved.  This was repeated after PEEP had been increased 
from 3 to 6 and 9 cmH2O, respectively. For EELV and LCI calculations, two 
separate helium wash outs were made after recording the ELV, and the aver-
age was used for further calculations. ELV is reported as an average of ELV 
values from 60 seconds preceding the helium wash out (about 30 ELV values). 
Blood gases were drawn immediately before the helium wash outs to deter-
mine paCO2. Mean arterial blood pressure (MAP) was also recorded for each 
step. Figure 9 below shows the scheme used in study III.
 
Figure 9. Scheme of the study protocol for Study III. IAP A, B, C and D, where IAP was 
randomly varied between either A/B=6 mmHg and C/D=12 mmHg or A/B=12 mmHg and 
C/D=6 mmHg.
Statistical methods
The statistical methods used are presented in each paper and the principles 
behind them are discussed in further detail in the background section of this 
thesis.
Distribution of data was checked with D’Agostino and Pearson omnibus 
K2 test for all studies. In study III a one-way ANOVA for repeated measure-
ments and Tukey’s multiple comparison test was used to assess variations in 
respiratory and haemodynamic parameters for each PEEP level. A paired t-
test was used to detect significant differences between ELV and EELV at indi-
vidual IAP steps within a PEEP level.  P<0.05 was considered to indicate sta-
tistical significance.
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Precision
Inherent precision was defined as two times the coefficients of variation 
(CV=SD/mean).26
Agreement and correlation between  
Dynamic Capnography and reference method
Agreement and limits of agreement (bias +/- (1.96xSD)) between COEPBF/ELV 
and reference methods were done with Bland Altman analysis in all studies.28 
Bias is expressed as the mean difference between COEPBF and the reference 
methods. 
Correction for repeated measurements was not done given that each mea-
surments is performed in a new situation where the reference value varies in a 
minor to moderate manner and thus represents independent serial measure-
ments rather that repeated measurments.30,31 
Mean percentage error for COEPBF  and the reference methods were defined 
as 1.96 x SD of the difference between the techniques divided by the mean of 
the reference technique as suggested by Critchley.36 A priori, a mean percent-
age error less or equal to 30% was considered to indicate clinical useful reli-
ability of COEPBF  compared with the reference method.36
In study III, correlation analyses between ELV and Helium wash-out were 
done using Pearson’s correlation coefficient test. 
Trending – ability to detect change
The ability of COEPBF and ELV to track changes in CO and FRC, was assessed 
by concordance calculation (the proportion of measurements that change in 
the same direction when COEPBF or ELV and reference method are compared). 
In study I and II, a 10% central exclusion zone of was chosen, extrapolated 
from the precision of the reference methods. For COFick vs COEPBF in study II 
and for Helium wash-out vs ELV in study III, a standard 15% zone was used .37
Statistical Software 
GraphPad Prism (version 7.0 for Windows, GraphPad Software, San Diego, 
CA, USA) was used for all statistical calculations and Microsoft Excel for Mac 
2011 version 14.5.7 for data handling.
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5  R ESULTS
All animals in the experimental parts survived the experiment. Parts of data 
from one animal was excluded from paper II and III due to techical issues with 
data sampling. 
STUDY I
The calculated inherent precision was ± 4% and ± 12% for COEPBF and COSSD, 
respectively in the clinical part and ± 6% and ± 4% for COEPBF and COTS, re-
spectively, in the laboratory part. 
In both the clinical and experimental sections, the haemodynamic inter-
ventionis lead to relatively small changes in the range of 10% in CO (Figure 10).
 
Figure 10. Time plot showing the relation between COEPBF and COSSD to the left and be-
tween COEPBF  and COTS to the right during the various haemodynamic challenges. Values 
are mean ± SD. n=15 in clinical study, n=9 in experimental study.  Note that CO in the 
human study is age dependent causing a large spread (cf. the reduced spread in the animal 
study).
Agreement 
Agreement for all paired data in the clinical section showed a mean bias be-
tween COSSD and COEPBF of 8.1 ml kg-1 min-1, 95% limits of agreement of −82 
to + 66 ml kg-1 min-1, and a mean percentage error of 48%. 
In the experimental part, agreement of mean bias between COEPBF  and 
COTS was 18 ml kg-1 min-1, with 95% limits agreement of -36 to + 38 ml kg-1 
min-1, and a mean percentage error of 31%. 
Trending ability
Concordance rate between COEPBF COSSD was 64% and 95% between COEPBF 
and COTS. 
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STUDY II
The calculated inherent precision were ±6% for COEPBF, ±4% for COTS and 
±28% for COFick. 
The hypoxic challenge and subsequent inhaled nitric oxide treatment re-
sulted in moderate haemodynamic changes in all animals as shown in Figure 11.
 
Median CO at baseline FiO2 1.0 was 2.7 L min-1 (2.6 to 2.9) for COEPBF, 
2.8 L min-1 (2.6 to 2.9) for COTS and 2.6 L min-1 (2.4 to 2.9) for COFick. 
Overall, COEPBF displayed parallel changes when compared to the COTS  and 
COFick. Adding inhaled nitric oxide resulted in an increase in CO for all meth-
ods. FiO2 concentration of 0.21 and above caused a decrease and return to 
baseline CO for all three methods as FiO2 reached 1.0.
Agreement 
For COEPBF vs COTS, agreement for all paired data showed a mean bias be-
tween COEPBF and COTS of 0.2 L min-1 (95% limits agreement of –0.5 to + 0.9 
L min-1) and a mean percentage error of 25%. Agreement between COEPBF 
and COFick for all paired data showed a mean bias of -0.1 L min-1 (95% limits 
agreement of -0.9 to + 0.6 L min-1) with an associated mean percentage error 
of 25%.
The corresponding values for COTS vs COFick was a mean bias of -0.1 L 
min-1 (95% limits agreement of of -0.6 to + 1 L min-1), with an associated mean 
percentage error of 30%.
Trending ability
The concordance between COEPBF/ COTS and  COEPBF / COFick was 86% and 
81% respectively.
Figure 11. Time plot 
showing the relation 
between COEPBF and 
COTS and COFick during 
the various states of 
hypoxic pulmonary 
hypertension. N=8-
10. Values are median 
(range).
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Figure 12. Changes in 
PaCO2 (kPa) in arterial 
blood and VCO2 (ml 
min-1) in response to  
increased PEEP for 
each IAP level. Values 
are mean±SD. n=7-8. 
*: P<0.05 IAP 0 mmHg 
vs IAP 6 mmHg within 
a PEEP. 
STUDY III
The inherent precision for ELV was 19%, 16% and 14% for PEEP 3, 6 and 9 cm-
H2O respectively at IAP 0 mmHg. Inherent precision for helium wash out has 
previously been shown to be approximately 12 %.44
Changes in respiratory parameters 
paCO2 and VCO2
Arterial paCO2 did not show any significant changes when increasing IAP 
from 0 to 6 to 12 mmHg at PEEP 9 cmH2O whereas a significant increase 
was seen for both PEEP 3 and 6 cmH2O when IAP was increased from 0 to 6 
(p=0.03 and 0.005 respectively). Increase of IAP from 6 to 12 mmHg did not 
cause any further significant changes in paCO2 at any PEEP level (Figure 11). 
VCO2 did not show any significant differences between IAP 0, 6 and 12 mmHg 
at PEEP level of 3 cmH2O. When increasing IAP to 6 mmHg however, a sig-
nificant increase in VCO2 was seen at PEEP 6 and 9 cmH2O (p<0.0001 and 
p=0.0004 respectively). Increase of IAP from 6 to 12 mmHg did not cause any 
further changes in VCO2  at any  PEEP  level (Figure 12).
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Changes in Lung clearance index 
PEEP 9 cmH2O was the only PEEP level capable of preserving LCI at a level 
close to normal values for all IAP levels. Furthermore, LCI was significantly 
lower at PEEP 9 cmH2O for all IAP levels when compared to PEEP 3 and 6 
cmH20 (p<0.05). 
Changes in EELV and ELV 
As expected, going from PEEP 3 to 6 and 9 cmH2O resulted in a significant 
increase in both EELV and ELV at IAP 0 mmHg (p<0.0001). EELV displayed a 
significant decrease from IAP 0 to 6 mmHg for all PEEP-levels (p<0.0001).  At 
PEEP 9 cmH2O, a significant decrease in EELV between IAP 6 and 12 mmHg 
was also noted, (p<0.0001).  
At PEEP 3 cmH2O, ELV decreased significantly from IAP 0 to 6 mmHg 
(p=0.04). No significant changes in ELV were detected for PEEP 6 cmH2O 
whereas ELV decreased significantly between IAP 0 and 6 when measured at 
PEEP 9 cmH2O (p<0.0001).  
At IAP 0 mmHg, ELV and EELV showed a strong and significant correla-
tion for all PEEP levels (r=0.78, p<0.0001). No significant correlation between 
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-4 ml kg-1, 95% limits of agreement -18 to 9 ml kg-1. For PEEP 9 cmH2O, 
ELV values were found to be significantly lower than EELV at IAP 0 mmHg 
(p=0.002) whereas no significant differences were found between ELV and 
EELV at IAP 6 (p=0.06) and IAP12 mmHg (p =0.7).
Trending ability
The concordance rate between EELV and ELV was calculated for PEEP 9 cm-
H2O only (this PEEP level being the only level displaying significant a correla-
tion between ELV and EELV). Using a 15 % exclusion zone, concordance was 
100 %. 
Changes in MAP
MAP increased significantly when going from IAP 0 to 6 mmHg at PEEP 6 
and 9 cm H20 (p=0.006 and p=0.03 respectively). No statistically significant 
differences in MAP were seen between the different PEEP levels within each 
IAP level (p<0.05).
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Based on an initial series of promising animal experiments covering the 
use of the capnodynamic concept in estimating effective pulmonary blood 
flow.10,11,68,69,71,72 we sought to examine COEPBF  as well as ELV for its per-
formance in the clinical paediatric population and in paediatric experimen-
tal animal settings. We did this using study designs and statistical methods 
as recommended by the current consensus in the CO research community. 
In study I and II, we found an overall good agreement for absolute values be-
tween dynamic capnography and reference methods based on transpulmo-
nary ultrasound and invasiv CO2-Fick. In the clinical setting dynamic cap-
nography appeared to perform in a more expected manner as compared to 
the reference method COSSD. In study III we found that dynamic capnography 
adequately reflects Helium wash-in/wash-out end expiratory lung volumes, 
provided that adequate PEEP is maintained. We also showed that this level of 
adequate PEEP, guarantees sufficient CO2 removal and preservation of lung 
homogeneity under laparoscopic conditions. The results and implications of 
these findings are discussed in further detail below. 
COEPBF in the clinical setting 
The main findings in study I was that COEPBF appears to be a reliable tech-
nique to monitor even minor CO deviations in children during anaesthesia. 
In the laboratory part of study I, COEPBF generated absolute values very close 
to the gold standard reference COTS.
Aspects on the reference method COEPBF
The calculated inherent precisions of COEPBF and COSSD were found to be 
within acceptable limits. COSSD did not detect the expected reduction in CO 
in response to an increase in PEEP whereas this reduction was detected by 
COEPBF. There are several reasons for this, but may partly be due to the com-
plexity and more situation-dependent nature of the COSSD method. Further-
more, the maximum decrease in CO in response to PEEP was in the region 
of 15%, making it difficult for COSSD to detect this given that its measured 
inherent precision of 12% requieres a least significant change of 12√2 ie ap-
proximately 17%. The fact that the elevation in CO in response to atropin was 
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detected by COSSD is more easily explained since this is related to the increased 
heart rate, conditions easily detected by COSSD. 
The accuracy of CO determination using COSSD is dependent on a precise 
estimation of the diameter of the aortic outflow tract since this factor is in-
cluded in the equation by the power of two (area of the aortic outflow tract = 
π x d22/4). In study I, the mean value of two different diameter measurments 
were used for COSSD calculations and this is has obvious implications for the 
accuracy of the calculated values. However, this is cannot explain why COSSD 
failed to detect the predicted reduction of CO caused by increased PEEP.
Increasing PEEP from 3 to 10 cmH2O caused a greater degree of lung ex-
pansion, thus altering intrathoracic conditions, making it more challenging 
to obtain adequate ultrasound projections. These alterations in intrathorac-
ic conditions required the sonographer to make continous small adjustment 
with the ultrasound probe thus potentially affecting the inherent precision 
of the reference method. Therefore it cannot be excluded that despite using 
an experienced sonographer, this may have added an imprecision caused by 
variations in the angle of the ultrasound beam to the measured blood flow, a 
known weakness of the COSSD technique 2.80
However, at PEEP 3 cmH2O the geometry of the thorax is constant be-
tween recordings and minimal or no ultrasound probe adjustments were 
needed. During these circumstances, COSSD could easily detect the CO in-
crease caused by atropine. COEPBF on th  e other hand, did not appear to be af-
fected by any PEEP induced changes in the geometry of the chest cavity. 
Since COSSD, unlike COEPBF, responded to the PEEP increase in an unex-
pected manner in the clinical study, we decided to use the exact same research 
protocol in an animal laboratory setting. This allowed us to compare COEPBF 
with the high precision gold standard COTS, to asses the agreement between 
the two methods and to investigate how pulmonary blood flow is affected by 
the haemodynamic interventions of the clinical protocol.
COEPBF in the laboratory setting of the clinical protocol  
The calculated inherent precision of COEPBF was of the same order of magni-
tude as in the clinical trial and compared well with the calculated inherent 
precision of COTS.
As in the clinical protocol, COEPBF detected a decrease in CO in response 
to elevations in PEEP. The same decrease was also detected by COTS, support-
ing the view that CO decreased in response to PEEP elevations also in the 
clinical part even if COSSD failed to detect this (for reasons discussed above). 
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Overall, COEPBF and COTS showed good agreement of absolute values for all 
paired recordings throughout the study protocol with a mean percentage er-
ror of 31%, ie very close to the a priori set 30% limit for maximum acceptable 
mean percentage error.36 From a practical perspective we therefore advocat-
ed that the values obtained with COTS and COEPBF can be regarded as near 
enough equal when measured under these circumstances.
Trending ability in the clinical and experimental context 
The concordance rate between COEPBF and COTS was 95 % in the experimen-
tal study and 64 % in the clinical study. There are a number of potential ex-
planations for the relatively poor concordance rate in the clinical study. For 
obvious reasons, in our clinical study, the magnitude of the acceptable hae-
modynamic provocations were limited by ethical restrains. We were therefore 
forced to induce relatively small CO variations. As mentioned above, the cal-
culated inherent precision for COSSD made it difficult for this reference meth-
od to detect these comparatively small changes in CO, making proper deter-
minations of trending ability challenging. 
In previous COEPBF studies using animals, the concordance between COEPBF 
and reference methods have generally been very high, even up to 100% in 
some studies.71 However, in these studies, CO alterations have been large, 
usually well above the methods inherent least significant change limits, thus 
resulting in a higher probability of good concordance. 
Contrary to the clinical study, concordance rate was found to be very 
good (95%) in the experimental study. The protocol in the experimental ani-
mal part, induced haemodynamic changes of the same magnitude as in the 
clinical protocol. In the experimental study however, both COEPBF and COTS 
detected these changes with a high concordance rate, thus suggesting that the 
lower concordance rate in the clinical part of the study possibly could be at-
tributed to the less reliable performance of COSSD.
The main finding in study II was that COEPBF was able to estimate and 
trend CO values with excellent correlation to the reference methods COFick 
and COTS during hypoxic selective pulmonary vasoconstriction and subse-
quent inhaled nitric oxide treatment.
Hypoxic challenge of the capnodynamic method
Selective hypoxic pulmonary vasoconstriction with subsequent pulmonary 
hypertension challenges a number of important factors with regards to the 
underlying assumptions of capnodynamic method, making this condition 
particularly interesting to examine. Selective hypoxic pulmonary vasocon-
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striction will primarily result in increased workload for the right ventricle ie 
potentially affecting pulmonary blood flow. Furthermore, pulmonary vaso-
constriction will recruit blood from small vessels within the lung tissue, there-
by potentially altering one of the prerequisites of the capnodynamic method, 
namely a stable inherent CO2 content of the pulmonary tissue including small 
lung vessels1. There is therefore a risk that the inherent CO2 content in the 
lung decreases as a consequence of pulmonary vasoconstriction, potentially 
affecting the accuracy of the capnodynamic  method.
The capnodynamic principle is based on estimations of lung end capil-
lary CO2 content, calculated from measurements of end tidal CO2 concentra-
tion. The physiological and mathematical principle behind this is discussed 
in further detail in the background section of this thesis. Hypoxia affects the 
CO2 content in whole blood by increasing CO2 loading and shifting the CO2 
dissociation curve upwards via the reverse Haldane effect81 as shown in Fig-
ure 14. At the steep part of the hemoglobin oxygen dissociation curve, oxy-
gen saturation can change quite dramatically in response to a given change 
in pO2.82 In fact, pO2 has been shown to oscillate during normal mechanical 
ventilation in healthy lungs83 and these oscillations are probably even more 
pronounced during hypoxia due to the steep slope of the hemoglobin oxy-
gen dissociation curve. Added to this, the experimental breathing pattern we 
used, could potentially contribute to make oscillations even more significant 
since this pattern increases variations in alveolar O2 and CO2 compared to a 
normal breathing cycle.
 
Under hypoxic conditions in our experimental setup, the position of the 
CO2 dissociation curve could therefore vary slightly, thus theoretically affecting 
the absolute values of the calculated COEPBF.
Figure 14. CO2-dissociation curve and 
the Haldane effect modified according to 
Teboul et al.81
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However, the issues addressed above did not seem to affect the CO moni-
toring ability of COEPBF compared to COFick and COTS in any relevant man-
ner. Hypoxia with measured SpO2 around 70% did not result in any signifi-
cant deterioration in agreement between COEPBF and the reference methods. 
Furthermore, no systematic change in the bias was detected when moving to 
increasing degrees of hypoxemia. 
The calculated mean percentage errors in study II were under all circum-
stances less than 25%. According to the a priori set 30% limit for maximum al-
lowed mean percentage error, we therefore suggested that COEPBF can be con-
sidered to be equally effective as the reference methods COTS and COFick when 
estimating CO during these conditions.
Trending ability during hypoxia 
COEPBF showed good trending ability compared with COTS with a concor-
dance rate of 86%. . We decided to use a 10% exclusion zone for this com-
parison rather than the commonly recommended 15% zone.37 The reason for 
this was the good calculated inherent precision of the reference technique. The 
choice of size of the exclusion zone is dependent on the inherent precision of 
the reference method. Simply put, the better the inherent precision, the small-
er the exclusion zone. This is further discussed in the background section of 
this thesis. This principle was clearly illustrated when assessing the trending 
capacity of COEPBF against COFick. We then found a comparatively poor con-
cordance rate (81%), well below the generally accepted 92% limit.37 The reason 
for this can most likely be attributed to the relatively poor inherent precision 
calculated for COFick (±28% for COFick vs ±6%  for COEPBF).
Impact of Pulmonary shunt in study I and II
It is important to take into consideration that the capnodynamic method es-
timates only the pulmonary blood flow that contributes to gas exchange, ie 
pulmonary shunt blood flow is not included. We did not determine the actual 
shunt in study II but in previous publications using an equivalent study setup, 
the shunt fractions have generally been in the region of 10 % ie relatively low .72
In the experimental part of study I, pulmonary shunt fraction was cal-
culated using Berggrens shunt formula84 and was on average 12 ± 2% during 
baseline conditions PEEP 3 cmH2O (data not published) ie corroborating pre-
vious results. In study II, where PEEP 5 cmH2O was used throughout the pro-
tocol, it is therefore likely to assume that the shunt was of similar magnitude.
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Laparoscopy- a “double hit” stress of the capnodynamic method 
The main findings in study III was that PEEP needs to be set to a minimal lev-
el of 9 cmH2O to preserve ventilation homogeneity, to ensure adequate VCO2 
and counteract increases in paCO2 during CO2 induced pneumoperitoneum 
in rabbits. Furthermore, PEEP 9 cmH2O enabled continuous ELV based FRC 
monitoring with values and trending that matched well with the helium wash 
out reference method. 
In previous studies ELV has been shown to closely reflect FRC under vari-
ous circumstances. This has been validated against both tracer gas wash-out 
techniques11,71 and computed tomography10 as mentioned in the background 
section of this thesis. 
Laparoscopic surgery is a clinically relevant scenario that from a theoreti-
cal point of view offers a double challenge for the capnodynamic estimation of 
FRC since it results both in a cranial shift of the diaphragm, ie reducing FRC, 
and simultaneously cause an increased CO2 load, both due to the active insuf-
flation of CO2 in the abdominal cavity.85, 86 In clinical practice, these effects 
would likely be even more pronounced if laparoscopic surgery is performed in 
infants and small children, something that is becoming increasingly popular 
worldwide.87 
PEEP levels necessary to optimize ventilation  
during pneumoperitoneum
A variety of ventilation strategies have been suggested to optimize FRC and 
preventing hypoxia and hypercarbia during laparoscopy. In our study, we 
choose to investigate how various PEEP levels affect ventilatory conditions 
during this situation since we considered the use of PEEP the most theoreti-
cally appealing approach to counteract reduced FRC, atelectasis development 
and potential gas exchange disturbances. The effects of PEEP on the various 
ventilatory parameters in study III are discussed in detail below. 
Effect on VCO2 and LCI
At an IAP of 0 mmHg, paCO2 was found to be relatively constant regardless 
of applied PEEP level. However, when exposed to an increased CO2 load (and 
a cranial shift of the diaphragm) due to abdominal CO2 insufflation, it is clear 
that PEEP 3 cm H2O was insufficient to allow for adequate increase of VCO2 
in response to the increased CO2 load. At IAP6 mmHg, both PEEP 6 cmH2O 
and PEEP 9 cmH2O were associated with increased VCO2 whereas at IAP12 
mmHg only PEEP 9 cmH2O was capable of further increasing VCO2, even 
if this increase was not statistically significant compared to PEEP 6 cmH2O. 
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during this situation since we considered the use of PEEP the most theoreti-
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and potential gas exchange disturbances. The effects of PEEP on the various 
ventilatory parameters in study III are discussed in detail below. 
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that PEEP 3 cm H2O was insufficient to allow for adequate increase of VCO2 
in response to the increased CO2 load. At IAP6 mmHg, both PEEP 6 cmH2O 
and PEEP 9 cmH2O were associated with increased VCO2 whereas at IAP12 
mmHg only PEEP 9 cmH2O was capable of further increasing VCO2, even 
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Furthermore, PEEP 9 cmH2O was superior in maintaining LCI within nor-
mal values despite the increases of IAP, thus indicating better lung homoge-
neity.
The reason why PEEP 9 cmH2O performed in a superior manner when 
compared to PEEP 3 cmH2O and PEEP 6 cmH2O regarding VCO2 and LCI 
may be explained by at least two different but still interrelated factors. First, 
PEEP 9 cmH2O is capable of keeping the lung constantly expanded, thereby 
avoiding both atelectasis formation and cyclic closing/reopening of the lung. 
This allowed for an adequate increase of VCO2 in response to the increased 
CO2 load when IAP was increased to 6 or 12 mmHg. Second, the increased 
abdominal pressure in itself (caused by CO2 insufflation) will cause a crani-
al shift of the diaphragm, resulting in a decreased FRC if unopposed. By in-
creasing PEEP the cranial shift of the diaphragm is counteracted, thereby bet-
ter preserving FRC. Thus, both the more adequate expansion of the lung and 
the partial protection against too pronounced cranial shift of the diaphragm 
when using PEEP 9 cmH2O help explain why this PEEP level appeared to be 
the best alternative to ensure satisfactory ventilation during pneumoperitone-
um in this model of laparoscopic surgery in small infants. 
Capnodynamic assessment of ELV during laparoscopy 
ELV and EELV displayed an overall strong correlation with acceptable agree-
ment for absolute values and good trending capacity when measured at PEEP 
9 cmH2O. No significant difference were seen between the absolute values of 
the methods for paired recorings done at 6 and 12 mmHg and the associated 
trending capacity was 100%.
Interestingly, PEEP 9 cmH2O was also the PEEP level that appeared to of-
fer best conditions for optimal lung homogeneity, as discussed above. 
Since the capnodynamic technique is based on the measurement of ex-
haled CO2, insufficient ventilation and excretion of CO2 will negatively affect 
the performance of the method.10,11 It is therefore not surprising that the best 
correlation between ELV and EELV was found when the lungs were in a state 
of optimal homogeneity and CO2 clearance. 
It is important to emphasize that even if specific ELV values were found 
to numerically be very close to the corresponding EELV recordings (provid-
ed that the lung is adequately expanded), ELV should not be viewed as syn-
onyms to EELV.71 This is because the two parameters strictly speaking referes 
to two different volumes, eventhough these volumes clearly are closely relat-
ed. EELV represents an anatomical volume whereas ELV quantifies the lung 
54
Furthermore, PEEP 9 cmH2O was superior in maintaining LCI within nor-
mal values despite the increases of IAP, thus indicating better lung homoge-
neity.
The reason why PEEP 9 cmH2O performed in a superior manner when 
compared to PEEP 3 cmH2O and PEEP 6 cmH2O regarding VCO2 and LCI 
may be explained by at least two different but still interrelated factors. First, 
PEEP 9 cmH2O is capable of keeping the lung constantly expanded, thereby 
avoiding both atelectasis formation and cyclic closing/reopening of the lung. 
This allowed for an adequate increase of VCO2 in response to the increased 
CO2 load when IAP was increased to 6 or 12 mmHg. Second, the increased 
abdominal pressure in itself (caused by CO2 insufflation) will cause a crani-
al shift of the diaphragm, resulting in a decreased FRC if unopposed. By in-
creasing PEEP the cranial shift of the diaphragm is counteracted, thereby bet-
ter preserving FRC. Thus, both the more adequate expansion of the lung and 
the partial protection against too pronounced cranial shift of the diaphragm 
when using PEEP 9 cmH2O help explain why this PEEP level appeared to be 
the best alternative to ensure satisfactory ventilation during pneumoperitone-
um in this model of laparoscopic surgery in small infants. 
Capnodynamic assessment of ELV during laparoscopy 
ELV and EELV displayed an overall strong correlation with acceptable agree-
ment for absolute values and good trending capacity when measured at PEEP 
9 cmH2O. No significant difference were seen between the absolute values of 
the methods for paired recorings done at 6 and 12 mmHg and the associated 
trending capacity was 100%.
Interestingly, PEEP 9 cmH2O was also the PEEP level that appeared to of-
fer best conditions for optimal lung homogeneity, as discussed above. 
Since the capnodynamic technique is based on the measurement of ex-
haled CO2, insufficient ventilation and excretion of CO2 will negatively affect 
the performance of the method.10,11 It is therefore not surprising that the best 
correlation between ELV and EELV was found when the lungs were in a state 
of optimal homogeneity and CO2 clearance. 
It is important to emphasize that even if specific ELV values were found 
to numerically be very close to the corresponding EELV recordings (provid-
ed that the lung is adequately expanded), ELV should not be viewed as syn-
onyms to EELV.71 This is because the two parameters strictly speaking referes 
to two different volumes, eventhough these volumes clearly are closely relat-
ed. EELV represents an anatomical volume whereas ELV quantifies the lung 
54
55
volume participating in gas exchange including the airway volume up to the 
site of the CO2 sensor and the carbon dioxide dissolved in lung tissue and lung 
capillary blood.11 It can therefore be challenging to strive for numerically per-
fect coherence between the methods, even when recordings are done under 
optimal conditions with regards to lung homogeneity. However, it must be 
considered a minimal requirement that ELV and EELV should display values 
in the same order of magnitude and offer excellent trending capacity, in or-
der for ELV to be considered reliable in the clinical context. In study III, these 
requirements were met only with PEEP 9 cmH2O and and it is therefore this 
level, that we suggested as most favorable for both optimal ventilation and for 
the performance of the capnodynamic method in estimating FRC during CO2 
pneumoperitoneum.
Hemondynamic effects of high PEEP 
One common concern is that application of high PEEP would result in reduced 
venous return, potentially affecting CO and MAP negeatively. The fact that in-
creased PEEP has circulatory effects on children is well established.88,89,90,91 
but the extent of this impact on haemodynamics is difficult to predict and is 
dependent on the underlying circulatory status of the patientet. In study I, we 
showed that increasing PEEP from 3 to 10 cmH2O in anaesthetized mechani-
cally ventilated infants, will only affect CO minimally (in the region of 10%, 
data not published).70 This indicates that PEEP levels around 10 cmH2O has 
minimal effects on CO and MAP, at least in healthy infants. 
In support of this, in study III the application of PEEP to 9 cmH2O during 
pneumoperitoneum and elevated IAP, was not associated with any heamody-
namic alterations, as demonstrated by a maintained mean arterial pressure 
during the increase of PEEP from 3 via 6 to 9 cmH2O. Thus, the use of a com-
paratively high PEEP level in this context, did not result in any negative cir-
culatory effects.
Pulmonary shunts during laparoscopy 
Pulmonary shunt fraction was not measured directly in study III, which is a 
limitation of the protocol. In this study however, FRC as measured with the 
gold standard EELV at PEEP 9 cmH2O, was between 15 and 34 ml kg-1 which 
is close to the normal range of EELV for most mammals (ie approximately 
25 ml kg-1), thus at least theoretically ensuring an adequately open lung with 
minimal atelectasis and shunting.92 Furthermore, lungomogeneity, as mea-
sured by LCI, was superior at PEEP 9 cmH2O which indicates an evenly ven-
tilted and open lung, with a high probablility of minimal shunting. 
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LIMITATIONS
The various limitations associated with the thesis studies have been addressed 
in the Background and Discussion sections of this thesis as well as in the sepa-
rate manuscripts. However, it is of special importance to highlight the follow-
ing more fundamental limitations of the dynamic capnography method:
1. Even if dynamic capnography now has been applied and validated in hu-
mans for the first time, further studies are needed for confirmation of ac-
curacy and to prove its usefulness in the clinical setting.
2. The lack of a true gold standard for CO measurements remains a restric-
tion for the validation of any new CO method, included COEPBF.
3. The definition of an acceptable agreement between a tested method and 
the reference method is currently set to a mean percentage error of less 
than 30%. This is, however, debatable and the importance of inherent pre-
cision for methods should be considered when judging the agreement. 
4. The studies are performed on three different species, humans, piglets and 
rabbits, making it difficult to compare results between the studies and 
challenging to draw overall conclusions. 
5. Dynamic capnography does not account for pulmonary shunted blood 
flow. Despite the use of established recruitment methods, we have no ra-
diographic verification of the level of lung expansion, which must be taken 
into account when interpreting the study results.
6. Under most circumstances ELV and FRC/EELV are closely related. How-
ever, they do represent two different entities, one anatomical and one 
functional, making the interpretaiton of their numerical conformity chal-
lenging. 
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FUTURE PERSPECTIVES
This thesis has evaluated dynamic capnography in a structured manner in ac-
cordance with the current consensus for CO and FRC validation studies, with 
encouraging results. The next natural step in the development is to further 
explore the method's limitations and usefulness in clinical contexts. Clinical 
observational studies and multicenter randomized controlled outcome stud-
ies are appropriate strategies for assessing the clinical benefit of the method. 
Introduction of the method in the intensive care environment would provide 
an interesting addition to this.
ELV has been shown to adequately reflect FRC in most situations. Both in 
the anaesthetic and intensive care environment, this can be used for studies 
on individually adjusted ventilation maneuvers with ELV as an endpoint of 
lung expansion. Again, clinical observational and outcome studies have to be 
undertaken to evaluate this.  
In the laboratory setting, DC needs to be further investigated for its limi-
tations during situations of abnormal physiology. From a paediatric perspec-
tive, an important and relatively common scenario is intra and extra cardiac 
shunting. In addition, single ventricle physiology and estimation of pulmo-
nary blood flow during persistent pulmonary hypertension of the newborn 
would potentially be of value in the care of children with congenital heart dis-
ease and compromised lung circulation.
Dynamic capnography allows for reliable estimation of some the param-
eters in Fick’s classic CO formula, thus, opening up mathematical derivation 
of the other parameters. Examples of this are mixed venous oxygen satura-
tion (SvO2) and shunt fraction estimations (both pulmonary and circulatory 
shunts).  Preliminary animal studies using invasive mixed venous blood gas 
sampling as reference method has already shown promising features. 
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7  CONCLUSIONS
During the various challenges performed in the studies, capnodynamic esti-
mation of CO and EELV were found to compare well with established com-
parative techniques. 
Specific conclusions
Study I
In the first human application of capnodynamic COEPBF we conclude that the 
method is clinicaly feasibel. 
In a porcine model resulting in moderate CO changes, COEPBF showed 
excellent agreement for absolute values and trending ability compared with 
the gold standard COTS. 
Against the findings of the porcine study, COEPBF appears more reliable 
compared to the current clinical standard, COSSD wih regards to the ability to 
dectet moderate changes in CO.
Study II
COEPBF show good agreement for absolute values and trending ability when 
compared to gold standard COTS in a setting of selective hypoxic pulmonary 
vasoconstriction. 
Study III
In a model of paediatric laparoscopic surgery, a PEEP level of 9 cmH2O is re-
quierd to preserve FRC, ventilation homogeneity and allow for adequate CO2 
clearance. 
ELV was found to adequately reflect FRC with good agreement of absolute 
values as well as good trending ability when compared against helium wash-
in/wash-out provided sufficent lung homogeneity.
58
7  CONCLUSIONS
During the various challenges performed in the studies, capnodynamic esti-
mation of CO and EELV were found to compare well with established com-
parative techniques. 
Specific conclusions
Study I
In the first human application of capnodynamic COEPBF we conclude that the 
method is clinicaly feasibel. 
In a porcine model resulting in moderate CO changes, COEPBF showed 
excellent agreement for absolute values and trending ability compared with 
the gold standard COTS. 
Against the findings of the porcine study, COEPBF appears more reliable 
compared to the current clinical standard, COSSD wih regards to the ability to 
dectet moderate changes in CO.
Study II
COEPBF show good agreement for absolute values and trending ability when 
compared to gold standard COTS in a setting of selective hypoxic pulmonary 
vasoconstriction. 
Study III
In a model of paediatric laparoscopic surgery, a PEEP level of 9 cmH2O is re-
quierd to preserve FRC, ventilation homogeneity and allow for adequate CO2 
clearance. 
ELV was found to adequately reflect FRC with good agreement of absolute 
values as well as good trending ability when compared against helium wash-
in/wash-out provided sufficent lung homogeneity.
58
59
8  ACKNOWLEDGMENTS
The completion of this thesis would not have been possible without the con-
tribution from all the amazing people that have helped me on the way. Here 
they are, 
Per-Arne Lönnqvist, my main supervisor. Thank you for taking me on board 
this exciting endeavor! You posses the enviable and impressive feature of being 
a Professor, while at the same time enjoy chatting about football over a pint. 
You have always struck me as a man who puts the bible on the floor! 
Per Winberg, co-supervisor, for your outstanding experience and knowledge 
of paediatric cardiology in general and cardiac ultrasound in particular! You 
have provided excellent help many times, both in research and in real situa-
tions with patients. Your cardiac echo knowledge is impressive! Thank you for 
all your help with Doppler measurments! Your attention to details has been 
especially useful!
Walid Habre, co-supervisor, for your help with so many things! Not only are 
you an exceptional researcher and clinician, you are also a down to earth per-
son with a very warm character! Thank you for being such an awesome host 
when we did our experiments in the lab in Geneva! I really hope I will be back 
in your lab some day.
Jonas Berner, head of the Department, for always supporting my research and 
for allowing my sabbatical leave so I could complete a clinical fellowship in 
the UK.
Peter Larsson and Katarina von Schewelov, my clinical directors for support-
ing my projects and giving me time off for research.
Mats Wallin, you are an outstanding scientist full of excellent ideas! You have 
also the rare capability of transforming them into actual research and publi-
cations! Also very impressed of how creative and hands on you are in the lab!
Magnus Hallbäck, for so many things! I really owe a lot to you for this thesis. 
Thank you for always taking a step back and double check the maths and sta-
tistics to see if my enthusiasm over results was justified….
59
8  ACKNOWLEDGMENTS
The completion of this thesis would not have been possible without the con-
tribution from all the amazing people that have helped me on the way. Here 
they are, 
Per-Arne Lönnqvist, my main supervisor. Thank you for taking me on board 
this exciting endeavor! You posses the enviable and impressive feature of being 
a Professor, while at the same time enjoy chatting about football over a pint. 
You have always struck me as a man who puts the bible on the floor! 
Per Winberg, co-supervisor, for your outstanding experience and knowledge 
of paediatric cardiology in general and cardiac ultrasound in particular! You 
have provided excellent help many times, both in research and in real situa-
tions with patients. Your cardiac echo knowledge is impressive! Thank you for 
all your help with Doppler measurments! Your attention to details has been 
especially useful!
Walid Habre, co-supervisor, for your help with so many things! Not only are 
you an exceptional researcher and clinician, you are also a down to earth per-
son with a very warm character! Thank you for being such an awesome host 
when we did our experiments in the lab in Geneva! I really hope I will be back 
in your lab some day.
Jonas Berner, head of the Department, for always supporting my research and 
for allowing my sabbatical leave so I could complete a clinical fellowship in 
the UK.
Peter Larsson and Katarina von Schewelov, my clinical directors for support-
ing my projects and giving me time off for research.
Mats Wallin, you are an outstanding scientist full of excellent ideas! You have 
also the rare capability of transforming them into actual research and publi-
cations! Also very impressed of how creative and hands on you are in the lab!
Magnus Hallbäck, for so many things! I really owe a lot to you for this thesis. 
Thank you for always taking a step back and double check the maths and sta-
tistics to see if my enthusiasm over results was justified….
59
60
Bronwyn Scarr for excellent help in study I and for proof reading.
Gergerly Fodor, for help with designing and conducting the experiments in 
Geneva. Awesome job! Also very good critical proof reading of my manuscript 
for that study!
Andre dS Rocha and Na Lin for excellent proof reading and ideas for study III.
Gergerly Albu and Sam Bayat for letting me see your fascinating research 
at the particle accelerator, European Synchrotron Radiation Facility ESRF, in 
Grenoble and for teaching me the helium wash in/wash-out technique there.
Anders Larsson and Miklós Lipcsey at Hedenstierna lab for excellent help and 
expertise in animal research. 
All technicians at The Hedenstierna lab for help with the animals and experi-
ence in conducting animal research. 
Staff and directors at the lab in Geneva for help with animal handling of the 
rabbits used in the studies there. Special thank to lab technician Xavier Belin 
for outstandingly skilled help with the animal preparation! 
Plastic surgeons Erik Neovius and Petra Petersson for help with patient re-
cruitment. 
Anders Modin, my external mentor, for excellent support and discussions! 
Lennart Christiansson, clinical mentor and Director of studies, when I was a 
registrar in Uppsala. You encouraged me to think in a critical and structured 
way. You once said that “just because someone hasn’t got a PhD, it does not 
mean that they are free from responsibility to think scientifically”. A philoso-
phy that has inspired me a lot!
All  anaesthetists and intensivists at BANE/BIVA!
Martin Räf, my clinical scheduler for the last 8 years. I honestly can’t remem-
ber one single occasion when you haven’t done all in your power to meet my 
requests for research time (or skiing).
Urban Fläring for hiring me back in 2011. Also Urban, thank you for show-
ing me the statistical software that I’ve used. It was an absolute game changer! 
I am absolutely certain that it saved me many months!
All anaesthetic nurses at BANE for helping me with the clinical research!
60
Bronwyn Scarr for excellent help in study I and for proof reading.
Gergerly Fodor, for help with designing and conducting the experiments in 
Geneva. Awesome job! Also very good critical proof reading of my manuscript 
for that study!
Andre dS Rocha and Na Lin for excellent proof reading and ideas for study III.
Gergerly Albu and Sam Bayat for letting me see your fascinating research 
at the particle accelerator, European Synchrotron Radiation Facility ESRF, in 
Grenoble and for teaching me the helium wash in/wash-out technique there.
Anders Larsson and Miklós Lipcsey at Hedenstierna lab for excellent help and 
expertise in animal research. 
All technicians at The Hedenstierna lab for help with the animals and experi-
ence in conducting animal research. 
Staff and directors at the lab in Geneva for help with animal handling of the 
rabbits used in the studies there. Special thank to lab technician Xavier Belin 
for outstandingly skilled help with the animal preparation! 
Plastic surgeons Erik Neovius and Petra Petersson for help with patient re-
cruitment. 
Anders Modin, my external mentor, for excellent support and discussions! 
Lennart Christiansson, clinical mentor and Director of studies, when I was a 
registrar in Uppsala. You encouraged me to think in a critical and structured 
way. You once said that “just because someone hasn’t got a PhD, it does not 
mean that they are free from responsibility to think scientifically”. A philoso-
phy that has inspired me a lot!
All  anaesthetists and intensivists at BANE/BIVA!
Martin Räf, my clinical scheduler for the last 8 years. I honestly can’t remem-
ber one single occasion when you haven’t done all in your power to meet my 
requests for research time (or skiing).
Urban Fläring for hiring me back in 2011. Also Urban, thank you for show-
ing me the statistical software that I’ve used. It was an absolute game changer! 
I am absolutely certain that it saved me many months!
All anaesthetic nurses at BANE for helping me with the clinical research!
60
61
All theatre staff at BANE for letting me sit with my laptop in theatre and write 
a large part of this thesis there!
Secretaries Lena Centervall and Lena Påhlsson for helping me with most of 
my administration. I promise I will try to get better in that area!
Ulf Johansson for layout and for making this collection of words actually look 
lika a book.
Colleagues at the Anaesthetic Departments at Gävle District General Hospi-
tal and Uppsala University Hospital, for many great years when I was a regis-
trar in anaesthesia and intensive care. 
Colleagues at Birmingham Children’s Hospital for introducing me to the 
world of paedatric anaesthesia
Former fellow colleagues and consultants at The Freeman Hospital Children’s 
Heart Unit in Newcastle for teaching me paediatric cardiac anaesthesia! I can’t 
see any better way to prepare for this thesis than going through the outstand-
ing training I got there!
My parents Lena and Göran for all your support and love throughout the 
years and for making this possible!
My siblings Ella, Axel, Henrik and Love. You have always been a huge inspi-
ration and motivation!
My wonderful kids Åke, Linus and Emma. I love you so much!
My dear Malin, you are an absolutely incredible partner and the love of my 
life. I love you!
This work was supported by the Karolinska Institute and partially by unre-
stricted grants from Maquet Critical Care AB, Solna Sweden, and the region-
al agreement on medical training and research (ALF) between Stockholm 
County Council and the Karolinska Institute.
61
All theatre staff at BANE for letting me sit with my laptop in theatre and write 
a large part of this thesis there!
Secretaries Lena Centervall and Lena Påhlsson for helping me with most of 
my administration. I promise I will try to get better in that area!
Ulf Johansson for layout and for making this collection of words actually look 
lika a book.
Colleagues at the Anaesthetic Departments at Gävle District General Hospi-
tal and Uppsala University Hospital, for many great years when I was a regis-
trar in anaesthesia and intensive care. 
Colleagues at Birmingham Children’s Hospital for introducing me to the 
world of paedatric anaesthesia
Former fellow colleagues and consultants at The Freeman Hospital Children’s 
Heart Unit in Newcastle for teaching me paediatric cardiac anaesthesia! I can’t 
see any better way to prepare for this thesis than going through the outstand-
ing training I got there!
My parents Lena and Göran for all your support and love throughout the 
years and for making this possible!
My siblings Ella, Axel, Henrik and Love. You have always been a huge inspi-
ration and motivation!
My wonderful kids Åke, Linus and Emma. I love you so much!
My dear Malin, you are an absolutely incredible partner and the love of my 
life. I love you!
This work was supported by the Karolinska Institute and partially by unre-
stricted grants from Maquet Critical Care AB, Solna Sweden, and the region-
al agreement on medical training and research (ALF) between Stockholm 
County Council and the Karolinska Institute.
61
62
9 R EFER ENCES
1.  Donati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli V, Pelaia 
P, Pietropaoli P. Goal-directed introperative therapy reduces morbidity 
and length of hospital stay in high-risk surgical patients.  
Chest, 2007, 132(6):1817–24.  
2. Bussières JS. Iatrogenic pulmonary artery rupture.  
Curr Opin Anaesthesiology. 2007;20(1):48-52.
3.  Montenij LJ, Buhre WF, Jansen JR, Kruitwagen CL, de Waal EE.  
Methodology of method comparison studies evaluating the validity of 
cardiac output monitors: a stepwise approach and checklist.  
Br J Anaesth. 2016;116(6):750–8  
4.   Nusmeier A, van der Hoeven JG, Lemson J. Cardiac output monitoring 
in pediatric patients. Expert Rev Med Devices. 2010 Jul;7(4):503-17.
5.  Absi MA, Lutterman J, Wetzel GT. Noninvasive cardiac output  
monitoring in the pediatric cardiac Intensive Care Unit.  
Curr Opin Cardiol. 2010;25(2):77-9.
6.  Heinze H, Eichler W. Measurements of functional residual capacity 
during intensive care treatment: the technical aspects and its possible 
clinical applications. Acta Anaesthesiol Scand. 2009;53(9):1121-30.
7.  Hammer J, Newth CJ. Infant lung function testing in the intensive care 
unit. Intensive Care Med. 1995;21(9):744-52.
8.  Schibler A, Frey U (2002) Role of lung function testing in the manage-
ment of mechanically ventilated infants.  
Arch Dis Child Fetal Neonatal Ed 87:F7–F10.
9.  Gedeon A, Krill P, Österlund B. Pulmonary blood flow (cardiac output) 
and the effective lung volume determined from a short breath hold us-
ing the differential Fick method.  
J Clin Monit Comput. 2002;17(5):313-21.
10.  Albu G, Petak F, Zand T, Hallbäck M, Wallin M, Habre W. Lung 
volume assessments in normal and surfactant depleted lungs: agree-
ment between bedside techniques and CT imaging. BMC Anesthesiol. 
2014;14:64.
62
9 R EFER ENCES
1.  Donati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli V, Pelaia 
P, Pietropaoli P. Goal-directed introperative therapy reduces morbidity 
and length of hospital stay in high-risk surgical patients.  
Chest, 2007, 132(6):1817–24.  
2. Bussières JS. Iatrogenic pulmonary artery rupture.  
Curr Opin Anaesthesiology. 2007;20(1):48-52.
3.  Montenij LJ, Buhre WF, Jansen JR, Kruitwagen CL, de Waal EE.  
Methodology of method comparison studies evaluating the validity of 
cardiac output monitors: a stepwise approach and checklist.  
Br J Anaesth. 2016;116(6):750–8  
4.   Nusmeier A, van der Hoeven JG, Lemson J. Cardiac output monitoring 
in pediatric patients. Expert Rev Med Devices. 2010 Jul;7(4):503-17.
5.  Absi MA, Lutterman J, Wetzel GT. Noninvasive cardiac output  
monitoring in the pediatric cardiac Intensive Care Unit.  
Curr Opin Cardiol. 2010;25(2):77-9.
6.  Heinze H, Eichler W. Measurements of functional residual capacity 
during intensive care treatment: the technical aspects and its possible 
clinical applications. Acta Anaesthesiol Scand. 2009;53(9):1121-30.
7.  Hammer J, Newth CJ. Infant lung function testing in the intensive care 
unit. Intensive Care Med. 1995;21(9):744-52.
8.  Schibler A, Frey U (2002) Role of lung function testing in the manage-
ment of mechanically ventilated infants.  
Arch Dis Child Fetal Neonatal Ed 87:F7–F10.
9.  Gedeon A, Krill P, Österlund B. Pulmonary blood flow (cardiac output) 
and the effective lung volume determined from a short breath hold us-
ing the differential Fick method.  
J Clin Monit Comput. 2002;17(5):313-21.
10.  Albu G, Petak F, Zand T, Hallbäck M, Wallin M, Habre W. Lung 
volume assessments in normal and surfactant depleted lungs: agree-
ment between bedside techniques and CT imaging. BMC Anesthesiol. 
2014;14:64.
62
63
11. Albu G, Wallin M, Hallbäck M, Emtell P, Wolf A, Lönnqvist PA, et al. 
Comparison of static end-expiratory and effective lung volumes for gas 
exchange in healthy and surfactant-depleted lungs.  
Anesthesiology. 2013;119(1):101-10.
12.  Fick A. Uber die Messung des Blutquantums in den Herzventrikeln. 
1870.  
12.  Jansen JR, Schreuder JJ, Mulier JP, Smith NT, Settels JJ, Wesseling KH. 
A comparison of cardiac output derived from the arterial pressure wave 
against thermodilution in cardiac surgery patients.  
Br J Anaesth. 2001;87(2):212-22.
13.  Jensen CS, Aagaard H, Olesen HV, Kirkegaard H. A multicentre, 
randomised intervention study of the Paediatric Early Warning Score: 
study protocol for a randomised controlled trial. Trials. 2017;18(1):267.
14.  Gan H, Cannesson M, Chandler JR, Ansermino JM. Predicting fluid 
responsiveness in children: a systematic review.  
Anesth Analg. 2013;117(6):1380-92.
15.  Oh GJ, Sutherland SM. Perioperative fluid management and  
postoperative hyponatremia in children.  
Pediatr Nephrol. 2016;31(1):53-60.
16.  von Ungern-Sternberg BS, Hammer J, Schibler A, Frei FJ, Erb TO.  
Decrease of functional residual capacity and ventilation homogeneity 
after neuromuscular blockade in anesthetized young infants and pre-
school children. Anesthesiology. 2006; 105:670-5.
17.  Canet J, Gallart L. Postoperative respiratory failure: pathogenesis,  
prediction, and prevention. Curr Opin Crit Care. 2014;20(1):56-62.
18.  Hedenstierna G. Optimum PEEP During Anesthesia and in Intensive 
Care is a Compromise but is Better than Nothing.  
Turk J Anaesthesiol Reanim. 2016;44(4):161-2.
19.  Hedenstierna G, Edmark L. Effects of anesthesia on the respiratory  
system. Best Pract Res Clin Anaesthesiol. 2015;29(3):273-84.
20.  Dreyfuss D, Saumon G. Role of tidal volume, FRC, and end-inspiratory 
volume in the development of pulmonary edema following mechanical 
ventilation. Am Rev Respir Dis. 1993;148(5):1194-203.
21.  Chamarthy MR, Kandathil A, Kalva SP. Pulmonary vascular  
pathophysiology. Cardiovasc Diagn Ther. 2018;8(3):208-13.
22.  Cherpanath TG, Lagrand WK, Schultz MJ, Groeneveld AB. Cardio-
pulmonary interactions during mechanical ventilation in critically ill 
patients. Neth Heart J. 2013;21(4):166-72.
63
11. Albu G, Wallin M, Hallbäck M, Emtell P, Wolf A, Lönnqvist PA, et al. 
Comparison of static end-expiratory and effective lung volumes for gas 
exchange in healthy and surfactant-depleted lungs.  
Anesthesiology. 2013;119(1):101-10.
12.  Fick A. Uber die Messung des Blutquantums in den Herzventrikeln. 
1870.  
12.  Jansen JR, Schreuder JJ, Mulier JP, Smith NT, Settels JJ, Wesseling KH. 
A comparison of cardiac output derived from the arterial pressure wave 
against thermodilution in cardiac surgery patients.  
Br J Anaesth. 2001;87(2):212-22.
13.  Jensen CS, Aagaard H, Olesen HV, Kirkegaard H. A multicentre, 
randomised intervention study of the Paediatric Early Warning Score: 
study protocol for a randomised controlled trial. Trials. 2017;18(1):267.
14.  Gan H, Cannesson M, Chandler JR, Ansermino JM. Predicting fluid 
responsiveness in children: a systematic review.  
Anesth Analg. 2013;117(6):1380-92.
15.  Oh GJ, Sutherland SM. Perioperative fluid management and  
postoperative hyponatremia in children.  
Pediatr Nephrol. 2016;31(1):53-60.
16.  von Ungern-Sternberg BS, Hammer J, Schibler A, Frei FJ, Erb TO.  
Decrease of functional residual capacity and ventilation homogeneity 
after neuromuscular blockade in anesthetized young infants and pre-
school children. Anesthesiology. 2006; 105:670-5.
17.  Canet J, Gallart L. Postoperative respiratory failure: pathogenesis,  
prediction, and prevention. Curr Opin Crit Care. 2014;20(1):56-62.
18.  Hedenstierna G. Optimum PEEP During Anesthesia and in Intensive 
Care is a Compromise but is Better than Nothing.  
Turk J Anaesthesiol Reanim. 2016;44(4):161-2.
19.  Hedenstierna G, Edmark L. Effects of anesthesia on the respiratory  
system. Best Pract Res Clin Anaesthesiol. 2015;29(3):273-84.
20.  Dreyfuss D, Saumon G. Role of tidal volume, FRC, and end-inspiratory 
volume in the development of pulmonary edema following mechanical 
ventilation. Am Rev Respir Dis. 1993;148(5):1194-203.
21.  Chamarthy MR, Kandathil A, Kalva SP. Pulmonary vascular  
pathophysiology. Cardiovasc Diagn Ther. 2018;8(3):208-13.
22.  Cherpanath TG, Lagrand WK, Schultz MJ, Groeneveld AB. Cardio-
pulmonary interactions during mechanical ventilation in critically ill 
patients. Neth Heart J. 2013;21(4):166-72.
63
64
23.  West JB: Respiratory physiology—the essentials, ed 9, Baltimore, 2012, 
Lippincott Williams & Wilkins.22
24.  Weaver LJ, Pierson DJ, Kellie R, Bonner B, Craig KC. A practical  
procedure for measuring functional residual capacity during mechani-
cal ventilation with or without PEEP. Crit Care Med. 1981;9(12):873-7.
25.  Odor PM, Bampoe S, Cecconi M. Cardiac Output Monitoring:  
Validation Studies - how Results Should be Presented.  
Curr Anesthesiol Rep. 2017;7(4):410-5.
26.  Cecconi M, Rhodes A, Poloniecki J, Della Rocca G, Grounds RM. 
Bench-to-bedside review: the importance of the precision of the refer-
ence technique in method comparison studies--with specific reference 
to the measurement of cardiac output. Crit Care. 2009;13(1):201
27.  Asuero A.G, Sayago A, González A.G. The Correlation Coefficient:  
An Overview.  
Critical Reviews in Analytical Chemistry. 2006. Volume 36; Issure 1.
28.  Bland JM, Altman DG. Statistical methods for assessing agreement 
between two methods of clinical measurement.  
Lancet. 1986;1(8476):307-10
29.  Myles PS, Cui J. Using the Bland-Altman method to measure agreement 
with repeated measures. Br J Anaesth. 2007;99(3):309-11.
30. Hapfelmeier A, Cecconi M, Saugel B. Cardiac output method compari-
son studies: the relation of the precision of agreement and the precision 
of method. J Clin Monit Comput. 2016;30(2):149-55
31. Montenij LJ, Buhre WF, Jansen JR, Kruitwagen CL, de Waal EE.  
Methodology of method comparison studies evaluating the validity of 
cardiac output monitors: a stepwise approach and checklist.  
Br J Anaesth. 2016;116(6):750-8
32.  Giavarina D. Understanding Bland Altman analysis.  
Biochem Med (Zagreb). 2015;25(2):141-51.
33. Drummond GB. Limits of agreement may have large confidence  
intervals. Br J Anaesth. 2016;116(3):430-1.
34.  Drummond GB. Limits of Agreement With Confidence Intervals Are 
Necessary to Assess Comparability of Measurement Devices.  
Anesth Analg. 2017;125(3):1075.
35.  Joosten A, Desebbe O, Suehiro K, Murphy LS, Essiet M, Alexander B, et al. 
Accuracy and precision of non-invasive cardiac output monitoring  
devices in perioperative medicine: a systematic review and meta-analysis†. 
Br J Anaesth. 2017;118(3):298-310.
64
23.  West JB: Respiratory physiology—the essentials, ed 9, Baltimore, 2012, 
Lippincott Williams & Wilkins.22
24.  Weaver LJ, Pierson DJ, Kellie R, Bonner B, Craig KC. A practical  
procedure for measuring functional residual capacity during mechani-
cal ventilation with or without PEEP. Crit Care Med. 1981;9(12):873-7.
25.  Odor PM, Bampoe S, Cecconi M. Cardiac Output Monitoring:  
Validation Studies - how Results Should be Presented.  
Curr Anesthesiol Rep. 2017;7(4):410-5.
26.  Cecconi M, Rhodes A, Poloniecki J, Della Rocca G, Grounds RM. 
Bench-to-bedside review: the importance of the precision of the refer-
ence technique in method comparison studies--with specific reference 
to the measurement of cardiac output. Crit Care. 2009;13(1):201
27.  Asuero A.G, Sayago A, González A.G. The Correlation Coefficient:  
An Overview.  
Critical Reviews in Analytical Chemistry. 2006. Volume 36; Issure 1.
28.  Bland JM, Altman DG. Statistical methods for assessing agreement 
between two methods of clinical measurement.  
Lancet. 1986;1(8476):307-10
29.  Myles PS, Cui J. Using the Bland-Altman method to measure agreement 
with repeated measures. Br J Anaesth. 2007;99(3):309-11.
30. Hapfelmeier A, Cecconi M, Saugel B. Cardiac output method compari-
son studies: the relation of the precision of agreement and the precision 
of method. J Clin Monit Comput. 2016;30(2):149-55
31. Montenij LJ, Buhre WF, Jansen JR, Kruitwagen CL, de Waal EE.  
Methodology of method comparison studies evaluating the validity of 
cardiac output monitors: a stepwise approach and checklist.  
Br J Anaesth. 2016;116(6):750-8
32.  Giavarina D. Understanding Bland Altman analysis.  
Biochem Med (Zagreb). 2015;25(2):141-51.
33. Drummond GB. Limits of agreement may have large confidence  
intervals. Br J Anaesth. 2016;116(3):430-1.
34.  Drummond GB. Limits of Agreement With Confidence Intervals Are 
Necessary to Assess Comparability of Measurement Devices.  
Anesth Analg. 2017;125(3):1075.
35.  Joosten A, Desebbe O, Suehiro K, Murphy LS, Essiet M, Alexander B, et al. 
Accuracy and precision of non-invasive cardiac output monitoring  
devices in perioperative medicine: a systematic review and meta-analysis†. 
Br J Anaesth. 2017;118(3):298-310.
64
65
36.  Critchley LA, Critchley JA. A meta-analysis of studies using bias and 
precision statistics to compare cardiac output measurement techniques. 
J Clin Monit Comput. 1999;15(2):85-91
37.  Critchley LA, Lee A, Ho AM. A critical review of the ability of con-
tinuous cardiac output monitors to measure trends in cardiac output. 
Anesth Analg. 2010;111(5):1180-92.
38.  Peyton PJ, Chong SW. Minimally invasive measurement of cardiac 
output during surgery and critical care: a meta-analysis of accuracy and 
precision. Anesthesiology. 2010;113(5):1220-35.
39.  Suehiro K, Joosten A, Murphy LS, Desebbe O, Alexander B, Kim SH, et al. 
Accuracy and precision of minimally-invasive cardiac output  
monitoring in children: a systematic review and meta-analysis.  
J Clin Monit Comput. 2016;30(5):603-20.
40.  Stetz CW, Miller RG, Kelly GE, Raffin TA. Reliability of the  
thermodilution method in the determination of cardiac output in  
clinical practice. Am Rev Respir Dis 1982; 126:1001–1004.
41.  LaMantia KR, O’Connor T, Barash PG. Comparing methods of  
measurement: an alternative approach.  
Anesthesiology 1990; 72:781–783.
42.  Dean DA, Jia CX, Cabreriza SE et al. Validation study of a new transit 
time ultrasonic flow probe for continuous great vessel measurements. 
ASAIO J. 1996;42(5):M671-6
43.  Hundley WG, Li HF, Hillis LD, Meshack BM, Lange RA, Willard JE, et al. 
Quantitation of cardiac output with velocity-encoded, phase-difference 
magnetic resonance imaging. Am J Cardiol. 1995;75(17):1250-5.
44.  Schibler A, Henning R. Measurement of functional residual capacity in 
rabbits and children using an ultrasonic flow meter.  
Pediatr Res. 2001; 49:581-8.
45.  Brewer LM, Orr JA, Sherman MR, Fulcher EH, Markewitz BA.  
Measurement of functional residual capacity by modified multiple 
breath nitrogen washout for spontaneously breathing and mechanically 
ventilated patients. Br J Anaesth. 2011;107(5):796-805.
46.  Saugel B, Cecconi M, Wagner JY, Reuter DA. Noninvasive continuous 
cardiac output monitoring in perioperative and intensive care medicine. 
Br J Anaesth. 2015;114(4):562-75
47.  Sehgal A, McNamara PJ. Does point-of-care functional  
echocardiography enhance cardiovascular care in the NICU?  
J Perinatol. 2008;28(11):729-35.
65
36.  Critchley LA, Critchley JA. A meta-analysis of studies using bias and 
precision statistics to compare cardiac output measurement techniques. 
J Clin Monit Comput. 1999;15(2):85-91
37.  Critchley LA, Lee A, Ho AM. A critical review of the ability of con-
tinuous cardiac output monitors to measure trends in cardiac output. 
Anesth Analg. 2010;111(5):1180-92.
38.  Peyton PJ, Chong SW. Minimally invasive measurement of cardiac 
output during surgery and critical care: a meta-analysis of accuracy and 
precision. Anesthesiology. 2010;113(5):1220-35.
39.  Suehiro K, Joosten A, Murphy LS, Desebbe O, Alexander B, Kim SH, et al. 
Accuracy and precision of minimally-invasive cardiac output  
monitoring in children: a systematic review and meta-analysis.  
J Clin Monit Comput. 2016;30(5):603-20.
40.  Stetz CW, Miller RG, Kelly GE, Raffin TA. Reliability of the  
thermodilution method in the determination of cardiac output in  
clinical practice. Am Rev Respir Dis 1982; 126:1001–1004.
41.  LaMantia KR, O’Connor T, Barash PG. Comparing methods of  
measurement: an alternative approach.  
Anesthesiology 1990; 72:781–783.
42.  Dean DA, Jia CX, Cabreriza SE et al. Validation study of a new transit 
time ultrasonic flow probe for continuous great vessel measurements. 
ASAIO J. 1996;42(5):M671-6
43.  Hundley WG, Li HF, Hillis LD, Meshack BM, Lange RA, Willard JE, et al. 
Quantitation of cardiac output with velocity-encoded, phase-difference 
magnetic resonance imaging. Am J Cardiol. 1995;75(17):1250-5.
44.  Schibler A, Henning R. Measurement of functional residual capacity in 
rabbits and children using an ultrasonic flow meter.  
Pediatr Res. 2001; 49:581-8.
45.  Brewer LM, Orr JA, Sherman MR, Fulcher EH, Markewitz BA.  
Measurement of functional residual capacity by modified multiple 
breath nitrogen washout for spontaneously breathing and mechanically 
ventilated patients. Br J Anaesth. 2011;107(5):796-805.
46.  Saugel B, Cecconi M, Wagner JY, Reuter DA. Noninvasive continuous 
cardiac output monitoring in perioperative and intensive care medicine. 
Br J Anaesth. 2015;114(4):562-75
47.  Sehgal A, McNamara PJ. Does point-of-care functional  
echocardiography enhance cardiovascular care in the NICU?  
J Perinatol. 2008;28(11):729-35.
65
66
48.  Mukerji A, Diambomba Y, Lee SK, Jain A. Use of Targeted Neonatal 
Echocardiography and Focused Cardiac Sonography in Tertiary  
Neonatal Intensive Care Units: Time to Embrace It? J  
Ultrasound Med. 2016;35(7):1579-91.
49.  El-Khuffash A, Herbozo C, Jain A, Lapointe A, McNamara PJ.  
Targeted neonatal echocardiography (TnECHO) service in a Canadian 
neonatal intensive care unit: a 4-year experience.  
J Perinatol. 2013;33(9):687-90.
50.  Gan H, Cannesson M, Chandler JR, Ansermino JM.  
Predicting fluid responsiveness in children: a systematic review.  
Anesth Analg. 2013;117(6):1380-92.
51.  Julien F, Hilly J, Sallah TB, Skhiri A, Michelet D, Brasher C, et al. 
Plethysmographic variability index (PVI) accuracy in predicting fluid 
responsiveness in anesthetized children.  
Paediatr Anaesth. 2013;23(6):536-46.
52.  Stricker PA, Fiadjoe JE, Jobes DR. Predicting fluid responsiveness in 
children: are the studied indicators of value in the setting of loss and 
replacement? Br J Anaesth. 2011;107(5):816-7; author's reply 7.
53.  Fick A. Uber die messung des Blutquantums in den Hertzvent rikeln.
Sitzber Physik Med Ges Wurzburg July 9th: 36, 1870
54.  Tibby SM, Hatherill M, Marsh MJ, et al. Clinical validation of cardiac 
output measurements using femoral artery thermodilution with direct 
Fick in ventilated children and infants.  
Intensive Care Med  1997; 23: 987-991.  
55.  de Boode WP, HopmanJC, Daniels O, et al. Cardiac output  
measurement using a modified carbon dioxide Fick method:  
a validation study in ventilated lambs. Pediatr Res 2007; 61: 279-283. 
56.  Peyton PJ. Pulmonary carbon dioxide elimination for cardiac output 
monitoring in peri-operative and critical care patients: history and  
current status. J Healthc Eng. 2013;4(2):203-22.
57.  Capek JM and Roy RJ. Noninvasive Measurement of Cardiac Output 
During Partial CO2 Rebreathing.  
IEEE Transactions on Biomedical Engineering, 1988, 35: 653–61.  
58.  Suarez-Sipmann F, Bohm SH, Tusman G. Volumetric capnography:  
the time has come. Curr Opin Crit Care. 2014;20(3):333-9.
59.  Gedeon A, Forslund L, Hedenstierna G, Romano E. A new method for 
noninvasive bedside determination of pulmonary blood flow.  
Med Biol Eng Comput, 1980, 18: 411–18  
66
48.  Mukerji A, Diambomba Y, Lee SK, Jain A. Use of Targeted Neonatal 
Echocardiography and Focused Cardiac Sonography in Tertiary  
Neonatal Intensive Care Units: Time to Embrace It? J  
Ultrasound Med. 2016;35(7):1579-91.
49.  El-Khuffash A, Herbozo C, Jain A, Lapointe A, McNamara PJ.  
Targeted neonatal echocardiography (TnECHO) service in a Canadian 
neonatal intensive care unit: a 4-year experience.  
J Perinatol. 2013;33(9):687-90.
50.  Gan H, Cannesson M, Chandler JR, Ansermino JM.  
Predicting fluid responsiveness in children: a systematic review.  
Anesth Analg. 2013;117(6):1380-92.
51.  Julien F, Hilly J, Sallah TB, Skhiri A, Michelet D, Brasher C, et al. 
Plethysmographic variability index (PVI) accuracy in predicting fluid 
responsiveness in anesthetized children.  
Paediatr Anaesth. 2013;23(6):536-46.
52.  Stricker PA, Fiadjoe JE, Jobes DR. Predicting fluid responsiveness in 
children: are the studied indicators of value in the setting of loss and 
replacement? Br J Anaesth. 2011;107(5):816-7; author's reply 7.
53.  Fick A. Uber die messung des Blutquantums in den Hertzvent rikeln.
Sitzber Physik Med Ges Wurzburg July 9th: 36, 1870
54.  Tibby SM, Hatherill M, Marsh MJ, et al. Clinical validation of cardiac 
output measurements using femoral artery thermodilution with direct 
Fick in ventilated children and infants.  
Intensive Care Med  1997; 23: 987-991.  
55.  de Boode WP, HopmanJC, Daniels O, et al. Cardiac output  
measurement using a modified carbon dioxide Fick method:  
a validation study in ventilated lambs. Pediatr Res 2007; 61: 279-283. 
56.  Peyton PJ. Pulmonary carbon dioxide elimination for cardiac output 
monitoring in peri-operative and critical care patients: history and  
current status. J Healthc Eng. 2013;4(2):203-22.
57.  Capek JM and Roy RJ. Noninvasive Measurement of Cardiac Output 
During Partial CO2 Rebreathing.  
IEEE Transactions on Biomedical Engineering, 1988, 35: 653–61.  
58.  Suarez-Sipmann F, Bohm SH, Tusman G. Volumetric capnography:  
the time has come. Curr Opin Crit Care. 2014;20(3):333-9.
59.  Gedeon A, Forslund L, Hedenstierna G, Romano E. A new method for 
noninvasive bedside determination of pulmonary blood flow.  
Med Biol Eng Comput, 1980, 18: 411–18  
66
67
60.  Gedeon A, Krill P, Osterlund B. Pulmonary blood flow (cardiac output) 
and the  effective lung volume determined from a short breath hold 
using the differential Fick  method. Journal of clinical monitoring and 
computing. 2002;17(5):313-21.  
61.  Hällsjö-Sander C, Sigmundsson T, Hallbäck M, Sipmann FS, Wallin 
M, Oldner A, et al. A modified breathing pattern improves the perfor-
mance of a continuous capnodynamic method for estimation of  
effective pulmonary blood flow. J Clin Monit Comput. 2017;31(4):717-25.
62.  Jaffe MB. Partial CO2 rebreathing cardiac output--operating principles 
of the NICO  system.  
Journal of clinical monitoring and computing. 1999;15(6):387-401.  
63.  Berton C, Cholley B. Equipment review: new techniques for cardiac 
output measurement--oesophageal Doppler, Fick principle using carbon 
dioxide, and pulse contour analysis. Crit Care. 2002;6(3):216-21.
64.  Botte A, Leclerc F, Riou Y, et al. Evaluation of a noninvasive cardiac 
output monitor in mechanically ventilated children.  
Pediatr Crit Care Med 2006; 7: 231-236.
65.  Mathews L, Singh RK. Cardiac output monitoring.  
Ann Card Anaesth 2008; 11: 56-68.  
66.  Peyton PJ, Venkatesan Y, Hood SG, Junor P, May C. Noninvasive, 
automated and continuous cardiac output monitoring by pulmonary 
capnodynamics: breath-by-breath comparison with ultrasonic flow 
probe. Anesthesiology. 2006;105(1):72-80.
67.  Peyton PJ. Continuous minimally invasive peri-operative monitoring of 
cardiac output by pulmonary capnotracking: comparison with ther-
modilution and transesophageal echocardiography.  
J Clin Monit Comput. 2012;26(2):121-32.
68.  Hällsjö-Sander C, Hallbäck M, Wallin M, Emtell P, Oldner A, Björne H. 
Novel continuous capnodynamic method for cardiac output assessment 
during mechanical ventilation. Br J Anaesth. 2014;112(5):824-31. 
69.  Hällsjö-Sander C, Hallbäck  M, Suarez Sipmann F, Wallin M, Oldner 
A, Björne  H. A novel continuous capnodynamic method for cardiac 
output assessment in a porcine model of lung lavage.  
Acta Anaesthesiol Scand. 2015;59(8):1022-31.
70.  Karlsson et al. Validation of capnodynamic determinations of cardiac 
output (Effective Pulmonary Blood Flow, EPBF) in anaesthetized chil-
dren: a human and porcine study.  
Submitted and under review British Journal of Anaesthesia 2018.
67
60.  Gedeon A, Krill P, Osterlund B. Pulmonary blood flow (cardiac output) 
and the  effective lung volume determined from a short breath hold 
using the differential Fick  method. Journal of clinical monitoring and 
computing. 2002;17(5):313-21.  
61.  Hällsjö-Sander C, Sigmundsson T, Hallbäck M, Sipmann FS, Wallin 
M, Oldner A, et al. A modified breathing pattern improves the perfor-
mance of a continuous capnodynamic method for estimation of  
effective pulmonary blood flow. J Clin Monit Comput. 2017;31(4):717-25.
62.  Jaffe MB. Partial CO2 rebreathing cardiac output--operating principles 
of the NICO  system.  
Journal of clinical monitoring and computing. 1999;15(6):387-401.  
63.  Berton C, Cholley B. Equipment review: new techniques for cardiac 
output measurement--oesophageal Doppler, Fick principle using carbon 
dioxide, and pulse contour analysis. Crit Care. 2002;6(3):216-21.
64.  Botte A, Leclerc F, Riou Y, et al. Evaluation of a noninvasive cardiac 
output monitor in mechanically ventilated children.  
Pediatr Crit Care Med 2006; 7: 231-236.
65.  Mathews L, Singh RK. Cardiac output monitoring.  
Ann Card Anaesth 2008; 11: 56-68.  
66.  Peyton PJ, Venkatesan Y, Hood SG, Junor P, May C. Noninvasive, 
automated and continuous cardiac output monitoring by pulmonary 
capnodynamics: breath-by-breath comparison with ultrasonic flow 
probe. Anesthesiology. 2006;105(1):72-80.
67.  Peyton PJ. Continuous minimally invasive peri-operative monitoring of 
cardiac output by pulmonary capnotracking: comparison with ther-
modilution and transesophageal echocardiography.  
J Clin Monit Comput. 2012;26(2):121-32.
68.  Hällsjö-Sander C, Hallbäck M, Wallin M, Emtell P, Oldner A, Björne H. 
Novel continuous capnodynamic method for cardiac output assessment 
during mechanical ventilation. Br J Anaesth. 2014;112(5):824-31. 
69.  Hällsjö-Sander C, Hallbäck  M, Suarez Sipmann F, Wallin M, Oldner 
A, Björne  H. A novel continuous capnodynamic method for cardiac 
output assessment in a porcine model of lung lavage.  
Acta Anaesthesiol Scand. 2015;59(8):1022-31.
70.  Karlsson et al. Validation of capnodynamic determinations of cardiac 
output (Effective Pulmonary Blood Flow, EPBF) in anaesthetized chil-
dren: a human and porcine study.  
Submitted and under review British Journal of Anaesthesia 2018.
67
68
71.  Hällsjö Sander C, Lönnqvist PA, Hallbäck M, Sipmann FS, Wallin M, 
Oldner A, et al.  Capnodynamic assessment of effective lung volume 
during cardiac output manipulations in a porcine model.  
J Clin Monit Comput. 2016;30(6):761-9.
72.  Sigmundsson TS, Öhman T, Hallbäck M, Redondo E, Sipmann FS, 
Wallin M, et al.  
Performance of a capnodynamic method estimating effective  
pulmonary blood flow during transient and sustained hypercapnia.  
J Clin Monit Comput. 2017. May 11. doi: 10.1007/s10877-017-0021-3. 
[Epub ahead of print].
73.  External research funding 2017. www.ki.se
74.  Corporate partnering at Karolinska Institute, December 2017.  
www.ki.se
75.  Nishimura RA, Callahan MJ, Schaff HV, Ilstrup DM, Miller FA, Tajik AJ. 
Noninvasive measurement of cardiac output by continuous-wave Dop-
pler echocardiography: initial experience and review of the literature. 
Mayo Clin Proc. 1984;59(7):484-9.
76.  Siggaard-Andersen, P. D. Wimberley, N. Fogh-Andersen & I. H Gøthgen. 
Measured and derived quantities with modern pH and blood gas  
equipment: Calculation algorithms with 54 equations.  
Scandinavian Journal of Clinical and Laboratory Investigation Vol. 48, 
Iss. sup189, 1988.
77.  de Boode WP, Hopman JC, DaniÎls O, van der Hoeven HG, Liem KD.  
Cardiac output measurement using a modified carbon dioxide Fick 
method: a validation study in ventilated lambs.  
Pediatr Res. 2007;61(3):279-83
78.  McNulty W, Usmani OS. Techniques of assessing small airways  
dysfunction. Eur Clin Respir J. 2014; 1.
79.  Fuchs SI, Eder J, Ellemunter H, Gappa M. Lung clearance index:  
normal values, repeatability, and reproducibility in healthy children  
and adolescents. Pediatr Pulmonol. 2009; 44:1180-5.
80.  Hudson I, Houston A, Aitchison T, Holland B, Turner T.  
Reproducibility of measurements of cardiac output in newborn infants 
by Doppler ultrasound. Arch Dis Child. 1990;65(1 Spec No):15-9.29. 
81.  Teboul JL, Scheeren T. Understanding the Haldane effect.  
Intensive Care Med. 2017;43(1):91-3.
82.  Gomez-Cambronero J. The oxygen dissociation curve of hemoglobin: 
Bridging the gap between biochemistry and physiology.  
J Chem Educ. 2001;78(6):757.
68
71.  Hällsjö Sander C, Lönnqvist PA, Hallbäck M, Sipmann FS, Wallin M, 
Oldner A, et al.  Capnodynamic assessment of effective lung volume 
during cardiac output manipulations in a porcine model.  
J Clin Monit Comput. 2016;30(6):761-9.
72.  Sigmundsson TS, Öhman T, Hallbäck M, Redondo E, Sipmann FS, 
Wallin M, et al.  
Performance of a capnodynamic method estimating effective  
pulmonary blood flow during transient and sustained hypercapnia.  
J Clin Monit Comput. 2017. May 11. doi: 10.1007/s10877-017-0021-3. 
[Epub ahead of print].
73.  External research funding 2017. www.ki.se
74.  Corporate partnering at Karolinska Institute, December 2017.  
www.ki.se
75.  Nishimura RA, Callahan MJ, Schaff HV, Ilstrup DM, Miller FA, Tajik AJ. 
Noninvasive measurement of cardiac output by continuous-wave Dop-
pler echocardiography: initial experience and review of the literature. 
Mayo Clin Proc. 1984;59(7):484-9.
76.  Siggaard-Andersen, P. D. Wimberley, N. Fogh-Andersen & I. H Gøthgen. 
Measured and derived quantities with modern pH and blood gas  
equipment: Calculation algorithms with 54 equations.  
Scandinavian Journal of Clinical and Laboratory Investigation Vol. 48, 
Iss. sup189, 1988.
77.  de Boode WP, Hopman JC, DaniÎls O, van der Hoeven HG, Liem KD.  
Cardiac output measurement using a modified carbon dioxide Fick 
method: a validation study in ventilated lambs.  
Pediatr Res. 2007;61(3):279-83
78.  McNulty W, Usmani OS. Techniques of assessing small airways  
dysfunction. Eur Clin Respir J. 2014; 1.
79.  Fuchs SI, Eder J, Ellemunter H, Gappa M. Lung clearance index:  
normal values, repeatability, and reproducibility in healthy children  
and adolescents. Pediatr Pulmonol. 2009; 44:1180-5.
80.  Hudson I, Houston A, Aitchison T, Holland B, Turner T.  
Reproducibility of measurements of cardiac output in newborn infants 
by Doppler ultrasound. Arch Dis Child. 1990;65(1 Spec No):15-9.29. 
81.  Teboul JL, Scheeren T. Understanding the Haldane effect.  
Intensive Care Med. 2017;43(1):91-3.
82.  Gomez-Cambronero J. The oxygen dissociation curve of hemoglobin: 
Bridging the gap between biochemistry and physiology.  
J Chem Educ. 2001;78(6):757.
68
69
83.  Formenti F, Bommakanti N, Chen R, Cronin JN, McPeak H,  
Holopherne-Doran D, et al. Respiratory oscillations in alveolar oxygen 
tension measured in arterial blood. Sci Rep. 2017;7(1):7499.
84.  Berggren S. The oxygen deficit of arterial blood caused by  
non-ventilation parts of the lung.  
Acta Physiol Scand. 1942;4(Suppl 2):1–92.  
85.  Koivusalo AM, Lindgren L. Effects of carbon dioxide  
pneumoperitoneum for laparoscopic cholecystectomy.  
Acta Anaesthesiol Scand. 2000; 44:834-41.
86.  Vlot J, Wijnen R, Stolker RJ, Bax K. Optimizing working space in 
porcine laparoscopy: CT measurement of the effects of intra-abdominal 
pressure. Surg Endosc. 2013; 27:1668-73.
87.  Chan IH, Tam PK. Laparoscopic Inguinal Hernia Repair in Infants and 
Children: State-of-the-Art Technique.  
Eur J Pediatr Surg. 2017; 27:465-71.
88.  Ingaramo OA, Ngo T, Khemani RG, Newth CJ. Impact of positive  
end-expiratory pressure on cardiac index measured by ultrasound  
cardiac output monitor. Pediatr Crit Care Med. 2014;15(1):15-20.
89.  Gullberg N, Winberg P, Selldén H. Pressure support ventilation  
increases cardiac output in neonates and infants.  
Paediatr Anaesth. 1996;6(4):311-5.
90. Gullberg N, Winberg P, Selldén H. Changes in stroke volume cause 
change in cardiac output in neonates and infants when mean airway 
pressure is altered. Acta Anaesthesiol Scand. 1999;43(10):999-1004.
91. Gullberg N, Winberg P, Selldén H. Changes in mean airway pressure 
during HFOV influences cardiac output in neonates and infants.  
Acta Anaesthesiol Scand. 2004;48(2):218-23.
92.  Stahl WR. Scaling of respiratory variables in mammals.  
J Appl Physiol. 1967; 22:453-60.
69
83.  Formenti F, Bommakanti N, Chen R, Cronin JN, McPeak H,  
Holopherne-Doran D, et al. Respiratory oscillations in alveolar oxygen 
tension measured in arterial blood. Sci Rep. 2017;7(1):7499.
84.  Berggren S. The oxygen deficit of arterial blood caused by  
non-ventilation parts of the lung.  
Acta Physiol Scand. 1942;4(Suppl 2):1–92.  
85.  Koivusalo AM, Lindgren L. Effects of carbon dioxide  
pneumoperitoneum for laparoscopic cholecystectomy.  
Acta Anaesthesiol Scand. 2000; 44:834-41.
86.  Vlot J, Wijnen R, Stolker RJ, Bax K. Optimizing working space in 
porcine laparoscopy: CT measurement of the effects of intra-abdominal 
pressure. Surg Endosc. 2013; 27:1668-73.
87.  Chan IH, Tam PK. Laparoscopic Inguinal Hernia Repair in Infants and 
Children: State-of-the-Art Technique.  
Eur J Pediatr Surg. 2017; 27:465-71.
88.  Ingaramo OA, Ngo T, Khemani RG, Newth CJ. Impact of positive  
end-expiratory pressure on cardiac index measured by ultrasound  
cardiac output monitor. Pediatr Crit Care Med. 2014;15(1):15-20.
89.  Gullberg N, Winberg P, Selldén H. Pressure support ventilation  
increases cardiac output in neonates and infants.  
Paediatr Anaesth. 1996;6(4):311-5.
90. Gullberg N, Winberg P, Selldén H. Changes in stroke volume cause 
change in cardiac output in neonates and infants when mean airway 
pressure is altered. Acta Anaesthesiol Scand. 1999;43(10):999-1004.
91. Gullberg N, Winberg P, Selldén H. Changes in mean airway pressure 
during HFOV influences cardiac output in neonates and infants.  
Acta Anaesthesiol Scand. 2004;48(2):218-23.
92.  Stahl WR. Scaling of respiratory variables in mammals.  
J Appl Physiol. 1967; 22:453-60.
69
